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Abstract 
Angiopoietin 1 (ANGPT1) is an endothelial growth factor and the ligand of the tyrosine 
endothelial kinase (TEK). The ANGPT-TEK system is known to mediate endothelial cell 
(EC) interactions and contributes to angiogenesis and vascular remodeling through 
angiocrine signaling. Although TEK is expressed in neural stem and progenitor cells, a 
vascular-independent role for ANGPT1 in neurogenesis is still unclear. This study 
focused on the embryonic expression of angiopoietins and their receptors in wild-type 
(WT) zebrafish (Danio rerio) and on further characterization of two zebrafish lines: the 
Angpt1sa14264 line, with a nonsense mutation in the angpt1 gene, and a transgenic line of 
angpt1 overexpression. Whole-mount in situ hybridization (WISH) and real-time 
quantitative polymerase chain reaction (RT-qPCR) showed a relatively high expression 
of angpt1 and tek throughout the first three days of WT development. Imaging of live 
Angpt1sa14264 and transgenic overexpression embryos revealed the bidirectional effect of 
angpt1 on the cardiovascular system, suggesting an essential role for normal embryonic 
development. In the absence of angpt1, gene expression analysis showed a dramatic 
disturbance in genes involved in neural patterning and neuronal development. The 
spatiotemporal expression of wingless-type MMTV integration site 1 (wnt1) implicated 
the midbrain-hindbrain boundary as a major site of Angpt1-mediated regulation of 
neuronal organization. The downregulated spatiotemporal expression of nestin (nes) 
indicated a decrease in neural progenitor-like cells throughout the central nervous system 
(CNS). In the context of angpt1 overexpression, the neurogenic locus notch homolog 1a 
(notch1a) was slightly increased despite the unchanged expression of all other neuronal 
markers and neural patterning genes analyzed. The spatiotemporal expression of notch1a 
was exacerbated in a large cranial vein, albeit detected in typical notch1a domains in the 
brain. These findings suggest that Angpt1 plays an important role in zebrafish 
embryogenesis and possibly regulates the organization of the zebrafish midbrain and 
hindbrain regions. 
 
 
 
Keywords: Angpt1, neurogenesis, Notch1a, Nes, neural patterning, Wnt1, midbrain-
hindbrain boundary 
  
 iv 
List of Abbreviations 
2-ΔΔCT Double delta CT 
ACTB1 Actin b1 
ANGPT1 Angiopoietin 1 
ANGPT2 Angiopoietin 2 
ANGPT3 Angiopoietin 3 
ANGPT4 Angiopoietin 4 
ANOVA Analysis of variance 
APOE Apolipoprotein E 
AS Antisense 
BBB Blood-brain barrier 
BCIP 5-Bromo-4-chloro-3′-indolyl-phosphate 
bp Base pair 
CCD Coiled-coil domain 
cDNA Complementary deoxyribonucleic acid 
CNS Central nervous system 
Cp Crossing point 
DIG Digoxigenin 
DNA Deoxyribonucleic acid 
dpf Day post-fertilization 
dsDNA Double-stranded deoxyribonucleic acid 
DTT 1,4-Dithiothreitol 
E. coli Escherichia coli 
EC Endothelial cell 
ECM Extracellular matrix 
EGF Epidermal growth factor 
EGFP Enhanced green fluorescent protein 
EPHA4 Erythropoietin-producing hepatocellular receptor A4 
EPHB4 Erythropoietin-producing hepatocellular receptor B4 
F1 Filial group 1 
F3 Filial group 3 
F5 Filial group 5 
F6 Filial group 6 
 v 
Figf c-Fos induced growth factor 
FN III Fibronectin type III 
fps Frame per second 
FReD Fibrinogen-like domain 
g g-force acceleration 
g Gram 
GFAP Glial fibrillary acidic protein 
h Hour 
HET Heterozygous 
hpf Hour post-fertilization 
HRM High resolution melting 
HSC Hematopoietic stem cell 
Ig Immunoglobulin 
ITGA5 Integrin subunit a5 
ITGAV Integrin subunit av 
ITGB1 Integrin subunit b1 
kb Kilobase 
KO Knockout 
L Liter 
LB Lysogeny broth 
LEC Lymphatic endothelial cell 
M Molar 
mg Milligram 
mL Milliliter 
mM Millimolar 
MO Morpholino 
mpf Month post-fertilization 
mRNA Messenger ribonucleic acid 
MS-222 Ethyl-3-aminobenzoate-methanesulfonate 
NBT Nitro-blue tetrazolium 
NES Nestin 
ng Nanogram 
nL Nanoliter 
 vi 
NMD Nonsense-mediated mRNA decay 
NOTCH1 Neurogenic locus notch homolog 1 
NPC Neural progenitor cell 
NSC Neural stem cell 
NVU Neurovascular unit 
ºC Degree Celsius 
P p-value 
PAX2 Paired box 2 
PAX5 Paired box 5 
PBS Phosphate-buffered saline 
PCNA Proliferating cell nuclear antigen 
PCR Polymerase chain reaction 
PFA Paraformaldehyde 
pH Potential of hydrogen 
PNS Peripheral nervous system 
PTU Phenylthiourea 
RNA Ribonucleic acid 
rpm Revolution per minute 
RT-qPCR Real-time quantitative polymerase chain reaction 
RTK Receptor tyrosine kinase 
S Sense 
SCD Super-clustering domain 
SD Standard deviation 
SEM Standard error of the mean 
SGZ Subgranular zone 
SOC Super optimal broth with catabolite repression 
SOX2 SRY-related HMG box 2 
SOX10 SRY-related HMG box 10 
SVZ Subventricular zone 
TAE Tris-acetate-EDTA 
TEK Tyrosine endothelial kinase 
TH Tyrosine hydroxylase 
TIE1 Tyrosine kinase with Ig-like and EGF-like domains 1 
TILLING Targeting induced local lesions in genomes 
 vii 
U Enzyme unit 
Ubi Ubiquitin 
UTP Uridine-5'-triphosphate 
UV Ultraviolet 
V Volt 
vs Versus 
VEGFA Vascular endothelial growth factor A 
VEGFB Vascular endothelial growth factor B 
VEGFC Vascular endothelial growth factor C 
VEGFD Vascular endothelial growth factor D 
VEGFR1 Vascular endothelial growth factor receptor 1 
VEGFR2 Vascular endothelial growth factor receptor 2 
VEGFR3 Vascular endothelial growth factor receptor 3 
WISH Whole-mount in situ hybridization 
WNT1 Wingless-type MMTV integration site 1 
WNT2B Wingless-type MMTV integration site 2B 
WNT10B Wingless-type MMTV integration site 10B 
WT Wild-type 
X-GAL 5-Bromo-4-chloro-3-indolyl-β-D-galactopyranoside 
ypf Year post-fertilization 
µg Microgram 
µL Microliter 
µm Micrometer 
µM Micromolar 
  
 viii 
Table of Contents 
1	 Introduction ............................................................................................................. 1	
2	 Review of the Literature ......................................................................................... 2	
2.1	 The vascular and nervous systems ................................................................. 2	
2.1.1	 Angiogenesis and lymphangiogenesis ................................................ 3	
2.1.2	 Neurogenesis and neural patterning .................................................. 4	
2.1.3	 The neurovascular link ...................................................................... 6	
2.2	 The ANGPT-TEK system .............................................................................. 9	
2.2.1	 Ligand and receptor structures ........................................................ 10	
2.2.2	 Signaling in the vascular compartment ........................................... 10	
2.2.3	 Non-vascular signaling .................................................................... 12	
2.3	 The zebrafish animal model ......................................................................... 14	
2.3.1	 Embryonic development ................................................................... 14	
2.3.2	 Genetic homology and manipulation ............................................... 15	
2.3.3	 Comparative brain biology .............................................................. 17	
3	 Hypothesis .............................................................................................................. 18	
4	 Aims ........................................................................................................................ 19	
5	 Materials and Methods ......................................................................................... 20	
5.1	 Zebrafish lines .............................................................................................. 20	
5.2	 Mutation confirmation by sequencing ......................................................... 21	
5.2.1	 RNA isolation and cDNA synthesis .................................................. 21	
5.2.2	 Polymerase chain reaction and gel DNA extraction ....................... 21	
5.2.3	 Cloning ............................................................................................. 22	
5.2.4	 Sequencing ....................................................................................... 24	
5.3	 Mutation screening by high resolution melting ........................................... 25	
5.3.1	 Genomic DNA isolation ................................................................... 25	
5.3.2	 High resolution melting analysis ..................................................... 25	
5.4	 Zebrafish transgenesis by Tol2kit ................................................................ 27	
5.5	 Zebrafish phenotyping ................................................................................. 28	
5.5.1	 Imaging of morphological features .................................................. 28	
5.5.2	 Imaging of vascular and non-vascular phenotypes ......................... 28	
5.5.3	 Statistics ........................................................................................... 29	
 ix 
5.6	 Quantification of mRNA expression by real-time quantitative polymerase 
chain reaction .......................................................................................................... 30	
5.6.1	 RNA isolation and cDNA synthesis .................................................. 30	
5.6.2	 Real-time quantitative polymerase chain reaction .......................... 30	
5.6.3	 Statistics ........................................................................................... 32	
5.7	 Whole-mount in situ hybridization .............................................................. 33	
5.7.1	 Sample preparation .......................................................................... 33	
5.7.2	 Probe synthesis ................................................................................ 33	
5.7.3	 In situ hybridization ......................................................................... 35	
6	 Results .................................................................................................................... 37	
6.1	 Expression of angiocrine factors during zebrafish embryogenesis .............. 37	
6.2	 Characterization of the Angpt1sa14264 line .................................................... 39	
6.2.1	 Genotypes of Angpt1sa14264 fish ........................................................ 39	
6.2.2	 Phenotypes of embryonic Angpt1sa14264 fish ..................................... 40	
6.2.3	 Gene expression screening in Angpt1sa14264 fish .............................. 43	
6.2.4	 Gene expression patterns in Angpt1sa14264 fish ................................ 46	
6.3	 Characterization of the transgenic overexpression model ........................... 51	
6.3.1	 Phenotypes of transgenic overexpression fish ................................. 51	
6.3.2	 Gene expression screening in transgenic overexpression fish ......... 53	
6.3.3	 Gene expression patterns of angpt1 and notch1a in transgenic 
overexpression fish ....................................................................................... 55	
7	 Discussion ............................................................................................................... 58	
7.1	 Angiopoietin 1 determines zebrafish embryonic phenotypes ...................... 59	
7.1.1	 Loss of angiopoietin 1 causes severe cardiovascular defects and 
embryonic lethality ....................................................................................... 59	
7.1.2	 Gain of angiopoietin 1 enhances blood perfusion ........................... 60	
7.2	 Angiopoietin 1 is implicated in embryonic angiogenesis, neural patterning 
and neuronal development ....................................................................................... 61	
7.2.1	 Angiopoietins, Tek and Tie1 receptors are expressed during 
embryogenesis .............................................................................................. 61	
7.2.2	 Loss of angiopoietin 1 perturbs neuronal organization, proliferation 
and differentiation ........................................................................................ 61	
7.2.3	 Gain of angiopoietin 1 has mild effects on gene expression ............ 65	
 x 
7.2.4	 Changes in angiopoietin 1 modulate gene expression in the nervous 
and vascular systems .................................................................................... 66	
7.3	 Conclusions and prospects ........................................................................... 68	
8	 References .............................................................................................................. 70	
9	 Acknowledgements ................................................................................................ 79	
10    Appendices ............................................................................................................. 80	
10.1	 Appendix A | Supplemental figures ............................................................. 80	
10.2	 Appendix B | Supplemental tables ............................................................... 81	
 
 1 
1 INTRODUCTION 
 
During development, the vascular and nervous systems establish a close relationship, with 
the patterning of both systems being driven and influenced by common factors and 
mechanisms (Bautch & James 2009). Post-developmentally, cross-talk between these two 
systems is ultimately responsible for constitutive neurogenesis and activation of 
regenerative neurogenic events following acute injury (Sawada et al 2014). 
The angiopoietins are endothelial growth factors known to bind specifically to the 
tyrosine endothelial kinase (TEK, previously TIE2). The ANGPT-TEK system mediates 
endothelial cell (EC) interactions and contributes to angiogenesis and vascular 
remodeling through angiocrine signaling (Augustin et al 2009). Besides its established 
role in angiogenesis and particularly in vascular quiescence, angiopoietin 1 (ANGPT1, 
previously ANG1) has also been suggested to play a role in neuronal proliferation and 
diversification despite the molecular mechanisms being widely unknown (Koutsakis & 
Kazanis 2016). 
Nervous system morphogenesis is achieved through controlled gradients of 
signaling molecules that induce the proliferation, migration and differentiation of neural 
progenitor cells (NPCs) and the organization of the nervous system in its distinct regions 
(Greene & Copp 2009). Several genes are involved in embryonic neurogenesis and their 
expression may be used as a marker for different events in the developing nervous system. 
The zebrafish (Danio rerio) is proposed as the developmental model best suited for this 
study due to its rapid development, easy genetic manipulation and maintenance. Using 
the zebrafish as a model, I tested the hypothesis that Angpt1 is an essential factor for 
embryonic neurogenesis. 
This study focused on the characterization of Angpt1 loss- and gain-of-function 
zebrafish lines: the Angpt1sa14264 line, carrying a nonsense mutation in the angpt1 gene, 
and a transgenic line of angpt1 overexpression. Characterization of these lines consisted 
of a phenotypical analysis of overall embryonic development and cardiovascular 
function, relative quantification of gene expression through a screening of markers of 
angiogenesis, neural development and patterning as well as analysis of expression 
patterns of selected markers in whole zebrafish embryos. 
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2 REVIEW OF THE LITERATURE 
 
2.1 The vascular and nervous systems 
Human physiology relies on the proper development and function of the different body 
systems. The close relationship between the vascular and nervous systems presents itself 
very early during development, and both systems follow similar patterning routes and 
share many common mechanisms (Carmeliet & Tessier-Lavigne 2005) (Figure 1). 
Clinically, the interdependency of these two systems is evidenced by the many 
pathological processes that may occur when this relationship is disrupted (Carmeliet 
2003). Neurodegenerative disorders caused by this disruption account for a small fraction 
of the global burden of disease. However, cardiovascular diseases and stroke remain the 
leading causes of death and severe long-term disability (World Health Organization 
2014). 
 
 
Figure 1 | Similarities in the patterning of the vascular and nervous systems. a, b, Anatomical 
representations of the vascular and nervous system, respectively. c, Branching of vessels (red) and nerves 
(green) towards common targets. Reproduced with permission from reference (Carmeliet & Tessier-
Lavigne 2005). 
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2.1.1 Angiogenesis and lymphangiogenesis 
The complexity of vertebrate organisms requires functional networks of blood and 
lymphatic vessels to meet tissue metabolic demands. Following vasculogenesis, the 
formation of primary capillary plexi from the mesoderm’s EC precursors, the hierarchy 
of the vasculature is established during early embryogenesis with the branching of large 
vessels into arteries, capillaries, veins and lymphatics. These processes, termed 
angiogenesis and lymphangiogenesis, continue to take place post-developmentally and 
coordinate the maintenance, post-injury regeneration and pathological remodeling of the 
vasculature (Adams & Alitalo 2007). 
Vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs) are 
responsible for many of the blood and lymphatic vessel morphogenic events during 
normal development and in pathological vessel remodeling (Ferrara et al 2003). VEGFA 
contributes to the proliferation and differentiation of EC precursors and in the activation 
of post-developmental angiogenic processes. Binding of VEGFA to VEGFR2 is strongly 
pro-angiogenic whereas its binding to VEGFR1 seems to trigger weakened VEGF 
activity (Koch & Claesson-Welsh 2012). The role of VEGFB as an angiogenic factor has 
been questioned due to it being dispensable for blood vessel growth. Nevertheless, it 
seems to regulate the expression of pro-survival genes in the vasculature through binding 
to neuropilin 1 and VEGFR1 (Zhang et al 2009). Equivalently to the roles of VEGFA and 
VEGFB in blood vessels, VEGFC and VEGFD are important for the regulation of 
lymphatic vessels. VEGFC is critical for lymphangiogenesis and promotes sprouting, 
proliferation and survival of lymphatic endothelial cells (LECs); VEGFD is a 
lymphangiogenic factor although not essential for the development of the lymphatic 
vessel network (Baldwin et al 2005, Karkkainen et al 2004). Regulatory functions of 
VEGFC and VEGFD are triggered mostly through binding to VEGFR3 despite possible 
interactions with VEGFR2 and neuropilin 2 (Karpanen et al 2006). In addition to the 
major contributions of VEGFs to angiogenesis and lymphangiogenesis, these molecules 
may play alternative roles in neural guidance, as evidenced by the trophic capabilities of 
VEGFC in oligodendrocyte progenitor cell populations and the promising therapeutic 
applications of VEGFA in motor neuron diseases (Le Bras et al 2006, Storkebaum et al 
2011). In parallel with the VEGFs, several other signaling molecules exert their influence 
in vascular development and homeostasis. Notably, the angiopoietins and their specific 
receptor, TEK, are angiocrine factors with important functions in angiogenic outgrowth, 
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vessel remodeling and maturation, and constitute major forces behind vascular 
quiescence and activation events (Fukuhara et al 2010). Aside from their context-
dependent regulation of angiogenesis, lymphangiogenesis and EC migration, 
angiopoietins have been shown to contribute to vessel permeability, hematopoiesis and 
inflammatory responses (Eklund & Olsen 2006, Thurston 2003). The angiopoietins, their 
known receptors, functions and signaling are discussed in more detail in section 2.2. 
 
 
2.1.2 Neurogenesis and neural patterning 
Neurogenesis and neural patterning, that is, the differentiation of neural stem cells (NSCs) 
into neurons and the controlled arrangement of nervous cells into organized tissues, 
respectively, are comprehensive processes during early embryonic development. These 
processes are initiated with the formation of the neural plate, the precursor of the central 
nervous system (CNS). The proliferation, migration and differentiation of NPCs from the 
neural plate are regulated by several signaling pathways and rely on the activation and 
repression of certain genes expressed by NPCs and their neighbors. The expression of 
these genes may serve as a molecular marker for different events in the development of 
the nervous system (Milet & Monsoro-Burq 2012). 
The neurogenic locus notch homolog 1 (NOTCH1) and the transcription factors 
paired box 2 (PAX2) and paired box 5 (PAX5) are important NSC markers (Blake & 
Ziman 2014, Shimojo et al 2011). NOTCH signaling is involved in the maintenance of 
NSC populations, controlling their self-renewal, proliferation, differentiation and 
apoptosis (Imayoshi et al 2010). During development, increased NOTCH activity is 
associated with quiescence of NPC populations whereas its inhibition induces NSC 
division and premature neuronal differentiation (Chapouton et al 2010). In addition to 
being a marker for NSCs, NOTCH is also important for EC quiescence, pericyte 
maturation and arterial differentiation (Roca & Adams 2007). Consistent with these roles, 
global changes in NOTCH signaling may be responsible for simultaneous effects in the 
nervous and vascular systems. The dynamic expression of PAX gene family members 
coordinates regional CNS development and contributes to neuronal cell fate specification. 
Regionalization of the developing brain is mediated by distinct PAX gene expression 
domains that respond differently to gradients of signaling molecules (Schwarz et al 1997). 
Both PAX2 and PAX5 are important transcription factors for midbrain and hindbrain 
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development, particularly in the regulation of midbrain-hindbrain boundary formation 
(Urbanek et al 1997). 
The proliferation and differentiation of NSCs is marked by the expression of 
proliferating cell nuclear antigen (PCNA) and nestin (NES), respectively. PCNA is 
important for the repair and replication of DNA. Although it is expressed throughout all 
stages of the cell cycle, its expression increases in phases of active cell division. 
Therefore, in the brain, PCNA is an indicator of actively proliferating NSCs (Kelman 
1997, Limke et al 2003). The intermediate filament protein NES is expressed in immature 
NPCs during development as well as in NSCs post-developmentally. NES expression is 
generally associated with a cell’s stem- and progenitor-like properties. Thus, 
downregulation of NES expression occurs upon differentiation of NPCs during 
development although it remains transiently high in the neurogenic niches of the adult 
brain (Gilyarov 2008, Lendahl et al 1990). 
Differentiated neurons and glial cells have specific gene expression profiles that 
differ from those of undifferentiated cells. Tyrosine hydroxylase (TH), apolipoprotein E 
(APOE) and glial fibrillary acidic protein (GFAP) are some of the neuronal markers 
expressed in specific mature neuronal cell populations. TH is a rate-limiting enzyme 
responsible for catalyzing the conversion of tyrosine to dopamine. Although expressed 
transiently in neuroblasts during development, TH is generally acknowledged as a marker 
for differentiated catecholamine neurons and endocrine cells (Cochard et al 1978). The 
expression of APOE and GFAP is associated with astrocytic glia of the CNS. APOE 
regulates systemic lipid transport and metabolism, in addition to its role in neuronal 
maintenance and repair whereas GFAP is a specific marker for activated mature 
astrocytes (Boyles et al 1985, Eng et al 1971). 
The erythropoietin-producing hepatocellular (EPH) receptor tyrosine kinase (RTK) 
family, the wingless-type MMTV integration site (WNT) protein family and the SRY-
related HMG box (SOX) family of transcription factors are among some of the most 
important regulators of patterning events in the developing nervous system. EPH 
receptors and their ligands, EPH receptor-interacting proteins (Ephrins), control cell 
migration and tissue stabilization by establishing cell-cell adhesion, tension or repulsion 
interactions between neighboring cells. Differential expression of gradients of EPHs and 
Ephrins within a tissue is responsible for the formation and maintenance of tissue 
boundaries (Wilkinson 2001). For instance, EPHA4 and EPHB4 are two members of this 
family with key roles in vertebrate hindbrain organization during embryogenesis. The 
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disruption of EPH signaling at tissue borders leads to increased border fluidity and cell 
intermingling (Cayuso et al 2015). In the developing vasculature, EphB receptors also 
regulate vessel morphogenesis through repulsive cues (Salvucci & Tosato 2012). WNT 
signaling proteins regulate diverse functions beyond their essential roles in the correct 
patterning of the CNS. WNT1 plays a critical role in the patterning and maintenance of 
the midbrain-hindbrain boundary and spinal cord, presumably through its canonical 
signaling pathway (Brault et al 2001). Moreover, WNT1 expression seems to have a 
restrictive effect on vertebrate hindbrain tissue boundaries and is suggested to prevent 
their expansion through a feedback loop that requires NOTCH signaling (Amoyel et al 
2005). In addition to WNT1, WNT10B and others are co-expressed at the rhombomere 
boundaries of the hindbrain and seem to have complementary functions in the regulation 
of hindbrain boundary integrity (Riley et al 2004). Another member of this family, 
WNT2B, has been proposed to influence hippocampal development and regulate retinal 
tissue organization and polarity (Grove et al 1998, Nakagawa et al 2003). Finally, the 
SOX transcription factors regulate stem and progenitor cell fates (Sarkar & Hochedlinger 
2013). Notably, SOX2 and SOX10 promote the maintenance of neural progenitor 
characteristics in cells of the CNS and the peripheral nervous system (PNS), respectively 
(Graham et al 2003, Kim et al 2003). 
 
 
2.1.3 The neurovascular link 
Blood flow in the brain is confined to a specialized vasculature, distinct from that of the 
periphery. The blood-brain barrier (BBB) is a physical boundary that protects the 
microenvironment of the brain from the circulating blood components (Muoio et al 2014). 
At the core of the BBB is the neurovascular unit (NVU), a structure that originates from 
the development and association of neuronal and vascular progenitor cells. The NVU is 
comprised of a complex and variable arrangement of ECs, pericytes, astrocytes, neurons, 
interneurons and basal lamina (Chen & Liu 2012) (Figure 2). 
Blood vessels in the brain are lined by modified ECs with tight and adherens 
junctions between adjacent cells (Stamatovic et al 2008). The resulting barrier protects 
the brain from potentially toxic solutes, neuroactive substances and waste products, while 
maintaining a homeostatic balance by allowing nutrients and ions to traverse between the 
two environments (Iadecola 2004). Pericytes, the mural cells that envelop the blood 
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vessels, are important regulators of vascular morphogenesis, maintenance and 
permeability (Armulik et al 2011). Due to their location in the NVU, pericytes can 
communicate directly with ECs, astrocytes and other pericytes (Sweeney et al 2016). 
Some subpopulations of these cells may be able to differentiate into other cell types and 
their degeneration has been shown to increase blood vessel permeability (Sakuma et al 
2016, Winkler et al 2011). 
Astrocytes are the supporting cells of the NVU although they assume multiple other 
roles such as acting as neuronal precursors during development (Sofroniew & Vinters 
2010). At the NVU, astrocytes are typically located between ECs and neurons, which 
facilitates their role as regulators of vascular integrity, by secreting growth factors during 
development and by establishing bidirectional signaling with ECs in the mature NVU 
(Broux et al 2015, Tanigami et al 2012). Neuronal processes in the NVU are responsible 
for communicating signals of the dynamic metabolic demands of the brain, resulting in 
regional regulation of vasoconstriction and vasodilation events (Peterson et al 2011). 
NPCs seem to assist in the stabilization of the developing vasculature, yet the role of 
neurons and interneurons in the maintenance and regulation of mature vessels is limited 
compared to that of astrocytes (Lacoste et al 2014, Ma et al 2013). 
The basal lamina is a layer of specialized extracellular matrix (ECM) and support 
proteins located between ECs and pericytes, and between pericytes and astrocytes 
(Ballabh et al 2004). The ECM is formed by many EC-secreted proteins which may 
interact with endothelial integrin receptors (Hawkins & Davis 2005). Among the support 
proteins of the basal lamina are growth factors, cytokines, matrix metalloproteases, lectins 
and semaphorins. The maintenance of this layer’s variable components is at the base of 
the functional heterogeneity observed in different regions of the BBB (McConnell et al 
2016). Perivascular macrophages and microglia are also present in the NVU, acting as a 
first line of defense against pathogens (Hickey & Kimura 1988). Additionally, smooth 
muscle cells are important components of the arterial NVU although absent from the 
capillary NVU (Zhang et al 2012). 
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Figure 2 | General representation of the NVU at the brain capillary level. The scheme shows a cross-
section of a cerebral blood capillary. Reproduced with permission from reference (Chen & Liu 2012). 
 
In addition to their structural role in the NVU, blood vessels are important for the 
survival and maintenance of specialized stem cell niches (Jones & Wagers 2008). Some 
vascular-derived effectors have been suggested to act both directly and indirectly in the 
CNS and its neurogenic areas, resulting in the promotion of neurogenesis, axonal 
sprouting and angiogenesis (Brumm & Carmichael 2012). Of such effectors, ANGPT1, a 
ligand of TEK, has been suggested to promote the proliferation and survival of 
neuroblasts although its interactions and the molecular mechanism whereby it contributes 
to neurogenesis remain largely unknown (Davis et al 1996, Goldberg & Hirschi 2009). 
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2.2 The ANGPT-TEK system 
The ANGPT-TEK system is comprised of several ANGPT and ANGPT-like molecules, 
and the receptors with which they interact (Figure 3). The ANGPT family consists of 
angiopoietins numbered 1 to 4 that bind to a common receptor, the TEK (Yancopoulos et 
al 2000). In addition to TEK, the tyrosine kinase with immunoglobulin and epidermal 
growth factor homology domains 1 (TIE1) is another receptor known to act as a co-
ANGPT receptor through heterodimerization with TEK (Marron et al 2000). 
 
 
Figure 3 | General structure of the angiopoietins, and the TEK and TIE1 receptors. The simplified 
protein structure of the angiopoietins includes a super-clustering domain (SCD) that allows 
multimerization, a coiled-coil domain (CCD), and a fibrinogen-like domain (FReD) that establishes binding 
to the TEK receptor. TEK and TIE1 have similar structures consisting of an Immunoglobulin (Ig)-like 
ligand binding domain, a triple epidermal growth factor (EGF)-like domain, another Ig-like domain, a triple 
fibronectin type III (FN III) domain, a single membrane pass, and an intracellular portion composed of two 
tyrosine kinase domains separated by a kinase insert. ANGPT1 and ANGPT4 are agonists (+) of TEK; 
ANGPT3, the mouse ortholog of ANGPT4, is an antagonist (-); and ANGPT2 is a context-dependent 
antagonist/agonist (-/+). Adapted from references (Barton et al 2014, Barton et al 2006). 
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2.2.1 Ligand and receptor structures 
The ANGPT ligands have a similar overall structure consisting of a C-terminal 
fibrinogen-like domain (FReD) followed by a coiled-coil domain (CCD) and a short N-
terminal super-clustering domain (SCD) (Davis et al 2003) (Figure 3). Four identified 
isoforms of ANGPT1 are thought to differentially regulate TEK activity, while 
angiopoietin 2 (ANGPT2, previously ANG2) has two alternatively-spliced isoforms that 
antagonize the TEK pathway (Huang et al 2000, Kim et al 2000). Human ANGPT1 and 
ANGPT2 have more than 60% homology in both their FReDs and CCDs whereas mouse 
angiopoietin 3 (ANGPT3) and human angiopoietin 4 (ANGPT4) are orthologs with 
approximately 50% homology with human ANGPT1 (Shim et al 2007). TEK and TIE1 
are single-pass type I RTKs with a high degree of similarity, particularly in their 
intracellular domains. The extracellular domains of these receptors contain an incomplete 
N-terminal Immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like 
domains followed by a complete Ig-like domain and three fibronectin type III (FN III) 
homology domains, while their intracellular regions consist of two tyrosine kinase 
domains, interrupted by a small kinase insert, and a C-terminal tail of tyrosine residues 
important for downstream signaling (Jones et al 2001) (Figure 3). The CCDs of ANGPT1 
and ANGPT2 mediate homo-oligomerization patterns resulting in their assembly in 
multimers capable of binding TEK. The molecular interaction of the angiopoietins with 
the TEK receptor occurs through binding of the ligand’s C-terminal FReD to the 
receptor’s N-terminal Ig-like domain (Macdonald et al 2006, Procopio et al 1999). 
 
 
2.2.2 Signaling in the vascular compartment 
Angiopoietins are crucial for the regulation of vascular and perivascular structures 
through the activation of downstream signaling events that modulate their survival, 
sprouting, stabilization and permeability (Brindle et al 2006). Here, the signaling by the 
angiopoietins with the receptors TEK and TIE1 and some integrins is reviewed in more 
detail. 
ANGPT1, naturally secreted by pericytes, is the main agonist of the TEK pathway 
(Sundberg et al 2002). Perivascular expression of ANGPT1 can recruit TEK and 
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phosphotyrosine vascular endothelial protein tyrosine phosphatase complexes to the EC 
junctions where they trans-associate leading to tightening and stabilization of the EC 
barrier. Constitutive ANGPT1-TEK binding in mature vessels sustains survival and 
adhesion of adjacent ECs, essentially resulting in vascular quiescence (Eklund & 
Saharinen 2013). In migrating ECs, during endothelial activation, ANGPT1 instead 
promotes TEK translocation to EC-ECM connections (Saharinen et al 2008). Moreover, 
ANGPT1 stimulates the enlargement and growth of blood vessels in ischemic tissues 
(Koh 2013). Unlike ANGPT1, ANGPT2 is produced in ECs and stored in Weibel-Palade 
bodies, but its expression in angiostatic vessels is typically lower than that of ANGPT1 
(Daly et al 2006). ANGPT2 is generally acknowledged as pro-angiogenic although it 
operates in a complex context-dependent manner (Maisonpierre et al 1997). The roles of 
ANGPT2 have been most thoroughly studied in tumor angiogenesis due to its 
upregulation in many cancers and tumor ECs. In mature tumor vessels, it can antagonize 
ANGPT1/TEK signaling whereas in immature ones it seems to activate TEK in the 
absence of ANGPT1. In contrast to ANGPT1, ANGPT2 destabilizes the EC barrier and 
increases vessel permeability, but also stimulates TEK translocation to EC-ECM contacts 
(Daly et al 2013). The interspecies orthologs ANGPT3 and ANGPT4 have been much 
less studied. Their exact functions are poorly characterized although they appear to act 
upon TEK in a cell-specific manner (Lee et al 2004). 
Despite the homology of the TEK and TIE1 receptors, a specific ligand for TIE1 is 
yet to be identified. The importance of TIE1 is evidenced by the regulatory roles that it 
may play in the ANGPT-TEK system. For instance, TIE1 can form constitutive 
heterodimeric complexes with TEK at the cell surface and such complexes seem to reduce 
the catalytic activity of TEK (Seegar et al 2010). Proteolytic processing of TIE1 has also 
been suggested to function as a physiological mechanism necessary for the control of 
TEK signaling (Marron et al 2007). Consistent with the hypothesis of TIE1 as a 
constitutive negative regulator of TEK signaling, ANGPT1 and ANGPT4 have been 
shown to induce TIE1 phosphorylation in ECs resulting in TEK activation, and the TEK-
agonistic role of ANGPT2 in LECs seems to be dependent on the absence of TIE1 
(Saharinen et al 2005, Song et al 2012). Although it can activate pathways in common 
with TEK, TIE1 remains a controversial member of the ANGPT-TEK system (Kontos et 
al 2002). 
The angiopoietins are versatile ligands that, in addition to TEK and TIE1, have been 
shown to interact with multiple integrin subunits and heterodimeric complexes in both 
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TEK/TIE1-dependent and -independent settings. Integrins are regulators of EC-EC and 
EC-ECM interactions though their influence extends beyond the vascular compartment 
(Rupp & Little 2001). For instance, integrins α5 and αv (ITGA5, ITGAV) have been 
previously linked to vascular remodeling during development and may form α5β1 and 
αvβ3 complexes that associate with both TEK and TIE1 receptors to promote interactions 
with ANGPT1 at EC-EC junctions (Cascone et al 2005, Dalton et al 2016, van der Flier 
et al 2010). Adding an extra layer of complexity to its context-dependent actions, 
ANGPT2 activates integrin β1 (ITGB1) and sensitizes the EC barrier to angiogenic 
signals in TEK-depleted ECs (Hakanpaa et al 2015). Additionally, in low TEK-
expressing endothelial tip cells of sprouting vessels, ANGPT2 seems to support 
angiogenesis by binding to αvβ3, αvβ5 and α5β1 integrins (Felcht et al 2012). 
In summary, the functions and regulation of ANGPT/TEK signaling in the vascular 
compartment are complex and not fully understood. Although angiopoietins are essential 
for vessel maturation, homeostasis and remodeling, their interaction with integrins may 
be at the base of non-vascular ANGPT signaling. 
 
 
2.2.3 Non-vascular signaling 
Although present in other cell types, high TEK expression is characteristic of ECs and 
their precursors (Schnurch & Risau 1993). In addition to ECs, TEK is expressed in tumor 
cells, hematopoietic stem cells (HSCs), white blood cells, NSCs, among others (Arai et 
al 2004, Huang et al 2010, Parati et al 2002, Puri & Bernstein 2003). The expression of 
angiopoietins and their receptors outside the vascular compartment point to possible 
parallel roles of this system in the regulation of processes such as inflammation, 
hematopoiesis and neurogenesis. 
ANGPT1 is broadly accepted as a regulator of vascular integrity with anti-
inflammatory properties. ANGPT2, on the other hand, seems to play a systemic pro-
inflammatory role. In fact, increased blood vessel permeability is critical for leukocyte 
adhesion and migration in acute inflammation (Milam & Parikh 2015). Although 
ANGPT2 may not have a direct role in the inflammatory process, it disrupts 
ANGPT1/TEK signaling, which in turn promotes vessel leakage and facilitates the access 
of immune cells and humoral effectors to damaged tissues (Roviezzo et al 2005). A recent 
study on the role of ANGPT1 in hematopoiesis revealed that osteocytes do not produce 
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ANGPT1 although it is produced in the stem and stromal cells of the bone marrow 
hematopoietic niches. In such niches, recovery of depleted HSC populations, blood cell 
production and blood vessel regeneration seem to be hastened in the absence of ANGPT1 
(Zhou et al 2015). In the nervous system, direct contacts between NSCs and ECs in the 
neurogenic niche maintain NSC quiescence through a mechanism involving NOTCH and 
EPH signaling (Ottone et al 2014). Endogenous NPCs have been shown to express TEK, 
pointing to a role for the angiopoietins in NSC regulation (Androutsellis-Theotokis et al 
2009). In fact, NSC populations expand in response to increased levels of ANGPT2 
stimulation, compatible with the coupling of pro-angiogenic and pro-neurogenic signals 
in a regenerative context (Androutsellis-Theotokis et al 2010). Interestingly, other studies 
have suggested roles for ANGPT1 in the proliferation and differentiation of NSCs in the 
adult neurogenic niche (Rosa et al 2010). Thus, in contrast to their predominantly 
opposing actions in vascular signaling, both ANGPT1 and ANGPT2 seem to stimulate 
NSC activation resulting in the proliferation and differentiation of these progenitor cell 
populations. 
As mentioned previously for ECs, the angiopoietins may signal through variable 
sets and combinations of integrin subunits in other cell types. For instance, ANGPT1 
promotes cardiac and skeletal myocyte survival, and both ANGPT1 and ANGPT2 can 
differentially promote cell-cell adhesion in TEK-negative fibroblasts, in integrin-
dependent ways (Carlson et al 2001, Dallabrida et al 2005). Evidence of TEK expression 
in mature neurons and their processes is lacking although some studies have suggested a 
role for ANGPT1 in the organization of neuronal processes in an ITGB1-dependent 
manner (Chen et al 2009a, Ward et al 2005). 
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2.3 The zebrafish animal model 
The zebrafish is an animal of the Cyprinidae family, native of Southeast Asia, and an 
extremely popular model for the study of developmental processes. The use of zebrafish 
in biomedical research is substantiated by its sufficient physiological and high genetic 
homology to higher species, including humans. Furthermore, the zebrafish has many 
advantages compared to other model organisms, among the most important: a rapid 
development and short life cycle, optical transparency during the embryonic and early 
larval stages, accessibility of genetic manipulations and sensitivity to pharmacological 
treatments (Kalueff et al 2014). As a translational model, the zebrafish has proven useful 
for studying complex disorders including those of the cardiovascular and nervous 
systems. The targeted development of increasingly accurate genetic manipulation, 
molecular investigation and imaging techniques, highlights the importance of the 
zebrafish as a model for preclinical studies (Phillips & Westerfield 2014). 
 
 
2.3.1 Embryonic development 
Sexually mature zebrafish can generate several dozens to hundreds of eggs on a 
weekly basis. Zebrafish eggs are fertilized ex utero and the resulting embryos develop in 
individual translucent chorions. Embryogenesis can be divided in seven periods 
associated with specific morphogenic events: zygote, cleavage, blastula, gastrula, 
segmentation, pharyngula and hatching (Kimmel et al 1995). Hatching of the embryo 
from the chorion typically occurs around 72 hours post-fertilization (72 hpf), or 3 days 
post-fertilization (3 dpf). After hatching, the embryos develop into larvae and later into 
adults (Spence et al 2008) (Figure 4). The primary structures of the cardiovascular and 
nervous systems in zebrafish are fully established by 1 dpf. Post-embryonically, the 
vascular network becomes increasingly differentiated into arteries, capillaries and veins, 
that stem from the large primary vessels. The brain increases in size and number of 
connections as well as in its organization into distinct regions (Ellertsdottir et al 2010, 
Schmidt et al 2013). 
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Figure 4 | Life cycle of the zebrafish. Fertilization of a zebrafish egg initiates a sequence of developmental 
processes. Important events and behaviors arising during each stage are indicated between stages. Stages 
include the embryo (0 hpf to 4 dpf), the larva (5 to 29 dpf), the young adult (30 dpf to 3 mpf), the mature 
adult (3 mpf to 2 ypf) and the aged adult (> 2 ypf). Adapted from reference (Stewart et al 2014). 
 
 
2.3.2 Genetic homology and manipulation 
Zebrafish genes have approximately 70% homology with human genes in their nucleotide 
sequences. Furthermore, 84% of all human genes currently associated with disease have 
at least one identified zebrafish ortholog, supporting the translational significance of 
biomedical research performed on zebrafish. Despite having occasionally duplicated or 
multiple copies of several genes, the encoded proteins typically execute overlapping 
functions in the zebrafish, similar or identical to those of their human counterparts. 
Moreover, similar developmental processes and overall physiology are largely based on 
the genetic conservation between both species (Howe et al 2013). 
As a classical model for the study of genetics, the zebrafish model has an array of 
approaches for genetic manipulation. These methods can be classified as forward or 
reverse genetic tools. Zebrafish gene knockdowns, knockouts and overexpression can be 
efficiently generated by various reverse genetic tools (Lawson & Wolfe 2011). Specific 
gene knockdowns can be achieved by antisense morpholino (MO) oligonucleotides that 
block translation or affect splicing processes. MOs are injected into fertilized eggs and 
their activity lasts up to several days (Bill et al 2009). A popular tool for the development 
of stable knockout (KO) mutants is the ‘targeting induced local lesions in genomes’ 
(TILLING) method. TILLING combines mutagenesis with exon sequencing to identify 
random mutations and generate stable lines with an isolated mutation (Moens et al 2008). 
Contrarily to gene knockdowns and knockouts, transgenic overexpression allows for 
gain-of-function studies. The Tol2kit is an adapted method for gene overexpression in 
zebrafish. Co-injection of a synthetic transposase mRNA with a DNA plasmid containing 
a promoter and the coding region of a specific gene allows for random integration of 
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foreign DNA copies in the genome of wild-type (WT) fertilized eggs. Insertion of the 
Tol2 in the germ cells of the injected animals can then be transmitted to further 
generations to establish stable overexpression lines (Kawakami 2007). The relevant 
human genes reviewed in the present study and their validated and provisional zebrafish 
counterparts are listed according to The Zebrafish Model Organism Database (Howe et 
al 2017) (Table 1). 
 
Table 1 | Relevant human genes and their zebrafish counterparts. 
Human gene Zebrafish gene ortholog(s) 
ANGPT1 angpt1 
ANGPT2 angpt2a, angpt2b* 
APOE apoea, apoeb* 
EPHA4 epha4a* 
EPHB4 ephb4a*, ephb4b* 
GFAP gfap 
ITGA5 itga5 
ITGAV itgav 
ITGB1 itgb1a, itgb1b* 
NES nes 
NOTCH1 notch1a* 
PAX2 pax2a, pax2b* 
PAX5 pax5 
PCNA pcna 
SOX2 sox2 
SOX10 sox10 
TEK tek 
TH th, th2* 
TIE1 tie1 
VEGFA vegfaa*, vegfab 
VEGFB vegfba* 
VEGFC vegfc 
VEGFD figf 
WNT1 wnt1 
WNT2B wnt2bb 
WNT10B wnt10b 
* Provisional ortholog 
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2.3.3 Comparative brain biology 
The zebrafish brain bears resemblance to the mammalian brain in organization, cellular 
morphology and neurochemistry (Panula et al 2010). The zebrafish CNS consists of the 
brain and the spinal cord. The brain is further organized into three regions: forebrain, 
midbrain and hindbrain. Analogously to the mammalian brain, specific areas of the 
zebrafish brain execute different functions although zebrafish cognitive ability and 
behaviors are simplified in comparison to those of humans. Zebrafish also possess a PNS 
with motor and sensory components, including visual, olfactory and auditory organs 
(Lieschke & Currie 2007). 
The brains of adult vertebrate organisms have variable neurogenic capacity, which 
often correlates with the abundance of adult NSCs and their niches, and with the 
distribution of brain areas for constitutive neurogenesis (Chapouton et al 2007). Despite 
harboring NSC niches and neurogenic areas like the subventricular zone (SVZ) and the 
subgranular zone (SGZ), the adult mammalian brain has a limited response for 
endogenous renewal and neuronal repair after an acute lesion (Jessberger 2016). In 
contrast, the adult zebrafish brain contains numerous proliferative zones and a more 
permissive environment for regeneration after injury, partly due to the absence of obvious 
glial scar tissue formation, a characteristic of mammals (Grandel et al 2006, Kizil et al 
2012). In adult mammalian and non-mammalian vertebrates, brain NSCs reside in highly 
vascularized environments (Goldman & Chen 2011). NSCs express several types of 
receptors susceptible to activation by diffused or membrane-bound factors in the niche. 
Due to the perivascular location of the NSC niche, the endothelium is an important source 
of factors that may determine the survival, proliferation, migration and differentiation of 
NSCs and NPCs (Masjkur et al 2012). 
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3 HYPOTHESIS 
 
ANGPT1 seems essential for the normal embryonic development, as evidenced by the 
lethality of transgenic mice deficient in Angpt1 during the embryonic stage (Suri et al 
1996). Furthermore, a knockdown of angpt1 expression alone induced a reduction in the 
brain size of zebrafish and guppy (Chen et al 2015). A recent study also showed that both 
prophylactic and post-injury ectopic expression of Angpt1 led to increased endogenous 
neuronal differentiation and improved functional recovery following brain vascular injury 
in rats (Meng et al 2014). Unpublished results from the Panula group showed high 
expression of angpt1 at the midbrain-hindbrain boundary during early developmental 
stages of zebrafish. Moreover, in a zebrafish angpt1 mutant, disturbances in the 
expression patterns of important neuronal markers (nes, notch1a, th), a stem cell maker 
(pax2a) and a glial marker (apoeb) were found between angpt1 KO and WT-like siblings. 
From a developmental standpoint, the role of ANGPT1 in neurogenesis could be 
indirectly linked to the regulation of angiogenesis and vascular maturation, a direct 
influence on signaling pathways required for neural patterning processes and maintenance 
of neural stem and progenitor cell populations, or a combination of these factors. Here, I 
tested the hypothesis that Angpt1 is an essential factor for developmental neurogenesis, 
particularly in the patterning of the zebrafish midbrain and hindbrain. 
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4 AIMS 
 
In this study, I aimed to investigate the role of Angpt1 during embryonic neurogenesis in 
the zebrafish. The specific aims under the scope of this study were: 
 
• Aim 1: Monitor the expression and localization of angiopoietins and their 
receptors in WT embryonic zebrafish. 
 
• Aim 2: Establish genetically-modified angpt1 KO and overexpression zebrafish 
lines. 
 
• Aim 3: Characterize angpt1 KO and overexpression embryonic zebrafish 
phenotypes. 
 
• Aim 4: Identify the key neurogenic factor or factors presumably linked to the 
actions of angpt1 in the zebrafish nervous system. 
 
• Aim 5: Evaluate the potential for translational application of the novel findings. 
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5 MATERIALS AND METHODS 
 
5.1 Zebrafish lines 
Zebrafish embryos and larvae of two different lines were selected for these experiments: 
a WT line (Turku) used for nearly two decades in experimental work (Eriksson et al 1998) 
and an angpt1 mutant line (Angpt1sa14264) generated by the TILLING method. 
Heterozygous (HET) male and female fish of the Angpt1sa14264 line were acquired at the 
F3 generation (Wellcome Trust Sanger Institute, Hinxton, UK). Further generations of 
this line were acquired by outcrossing Angpt1sa14264 heterozygotes with Turku wild-types. 
Angpt1 KO fish used in this study were obtained by inbreeding of F5 and F6 Angpt1sa14264 
HET pairs. Zebrafish eggs were obtained by in-house breeding for both lines. The 
fertilized eggs were collected immediately after spawning and raised in E3 medium at 28 
± 0.5 °C, in accordance with the guidelines of The Zebrafish Book (Westerfield 1995). 
All animals were staged in hpf or dpf and according to morphological criteria (Kimmel 
et al 1995). Animals at all stages of development were sacrificed by ice chilling. 
All work with the zebrafish was conducted at the research facilities of the 
University of Helsinki, in the Zebrafish Unit, Neuroscience Center and Department of 
Anatomy. Appropriate permits and approval for the experiments were obtained from the 
Regional Government of Southern Finland, in agreement with the European 
Commission’s ethical guidelines and legislation for the protection of animals used for 
scientific purposes. 
  
 21 
5.2 Mutation confirmation by sequencing 
 
5.2.1 RNA isolation and cDNA synthesis 
All independent RNA samples were isolated from pooled embryos or larvae by a RNeasy 
Mini Kit (Qiagen, Hilden, Germany). The concentration of RNA was measured by a 
BioPhotometer (Eppendorf, Hamburg, Germany). The total RNA was reverse-transcribed 
into cDNA using the SuperScript III Reverse Transcriptase (Invitrogen, Carlsbad, CA, 
USA). The first-strand cDNA synthesis reactions were performed in eppendorfs, in final 
volumes of 20 µL, including 2 µg of total RNA and 0.5 mM of dNTP (Thermo Fisher 
Scientific, Waltham, MA, USA), primed with 5 mg/L of Random Primer (Roche 
Diagnostics, Basel, Switzerland) incubated at 65 °C for 5 minutes followed by a 5-minute 
incubation on ice. After a brief centrifugation, 4 µL of 5X First-Strand Buffer, 0.01 M of 
DTT and 200 U SuperScript III RT (Invitrogen, Carlsbad, CA, USA) were added, 
followed by incubations at room temperature (approximately 20 °C) for 5 minutes, 50 °C 
for 90 minutes, 70 °C for 15 minutes, and stored at -80 °C until further use. 
 
 
5.2.2 Polymerase chain reaction and gel DNA extraction 
The amplification reactions were performed in polymerase chain reaction (PCR) tube 
strips, in 25 µL volumes containing 3 µL of genomic DNA, 0.4 µM of sa14264 primers 
(Oligomer, Helsinki, Finland) (Table 2), 0.2 mM of dNTP, 2.5 µL of Optimized 10X 
DyNAzyme Buffer and 2 U DyNAzyme II DNA Polymerase (Thermo Fisher Scientific, 
Waltham, MA, USA). The PCR cycling included an initial denaturation at 94 °C for 2 
minutes followed by 40 annealing cycles, each consisting of 20 seconds at 94 °C, 20 
seconds at 62 °C and 30 seconds at 72 °C, and a final extension step at 72 °C for 7 minutes. 
The PCR products were kept on hold, at 8 °C, until further processing. 
Gel electrophoresis was performed by loading the total volume of the PCR products 
thoroughly mixed in 6X DNA Loading Dye (Thermo Fisher Scientific, Waltham, MA, 
USA) into the wells of an agarose gel containing 1X TAE buffer (40 mM Tris (pH 7.6), 
20 mM acetic acid, 1 mM EDTA), 1% LE Standard Agarose (BioNordika, Stockholm, 
Sweden) and SYBR Safe DNA Gel Stain (Invitrogen, Carlsbad, CA, USA) 1:10000. A 
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volume of 4 µL of GeneRuler 1kb DNA Ladder (Thermo Fisher Scientific, Waltham, 
MA, USA) was loaded into the outer-most wells of the gel and a current of 100 V was 
applied for approximately 40 minutes. The DNA bands of the expected size were excised 
from the gel under UV light exposure and the DNA was extracted from the excised gel 
slices by a MinElute Gel Extraction Kit (Qiagen, Hilden, Germany). The concentration 
of dsDNA was measured by a BioPhotometer (Eppendorf, Hamburg, Germany) and the 
DNA samples were stored at -20 °C until further use. 
 
Table 2 | PCR primer information for amplification of the angpt1 mutation region in the Angpt1sa14264 
line. 
Primers Gene Sequence location Primer pair sequences (5’ → 3’) 
sa14264 F 
sa14264 R 
angpt1 exon 4, chromosome 19 
AAAGATGCAGGAGCTGGAGG 
AACATCATGCAGCACTCTCT 
 
 
5.2.3 Cloning 
The constructs were generated by assembling the pGEM-T Easy Vector (Promega, 
Madison, WI, USA) (Figure 5) and the DNA inserts, amplified as previously described. 
The ligation reactions were prepared in eppendorfs, in final volumes of 10 µL consisting 
of approximately 100 ng of DNA insert, 50 ng of pGEM-T Easy Vector, 5 µL of 2X 
Rapid Ligation Buffer and 3 U T4 DNA Ligase (Promega, Madison, WI, USA). The 
reactions were incubated overnight at room temperature. 
Competent E. coli bacteria of the DH5α strain (Invitrogen, Carlsbad, CA, USA) 
were transformed to exponentially replicate the constructs. To each eppendorf containing 
50 µL of DH5a suspension, 5 µL of ligation product was added, gently homogenized and 
incubated on ice for 30 minutes. Bacteria were then heat-shocked at 42 °C for 45 seconds 
to incorporate the construct, followed by a 2-minute incubation on ice. To obtain maximal 
transformation efficiency, 1 mL of SOC medium (2% tryptone, 0.5% yeast extract, 10 
mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4 and 20 mM glucose) was added 
to each eppendorf and the bacteria were incubated at 37 °C for 45 minutes. To pellet the 
bacteria, the eppendorfs were centrifuged for 1 minute at 13000 x g and the pellets were 
disrupted in 150 µL of the supernatant. A volume of 75 µL of the bacterial suspensions 
was evenly spread on LB agar ampicillin-selective plates (15 g/L agar, 10 g/L tryptone, 
10 g/L NaCl, 5 g/L yeast extract, 100 µg/mL ampicillin), in the presence of 1 mg of X-
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GAL (Affymetrix, Santa Clara, CA, USA) and incubated overnight at 37 °C. When grown 
in the presence of X-GAL, bacteria transformed with vectors containing recombinant 
DNA produced white colonies whereas cells transformed with non-recombinant plasmids 
grew into blue colonies. For each construct, four white colonies were picked from the 
agar plates and grown overnight at 37 °C with 250-rpm agitation in 3 mL of LB medium 
(10 g/L tryptone, 10 g/L NaCl, 5 g/L yeast extract) with 100 µg/mL of ampicillin (Thermo 
Fisher Scientific, Waltham, MA, USA). The plasmids were isolated and purified from the 
bacterial cultures by a QIAprep Spin Miniprep Kit (Qiagen, Hilden, Germany). 
Gel electrophoresis was performed with 1 µL of plasmid DNA, as previously 
described, and the DNA integrity was assessed through imaging of the gel under UV light 
exposure. The concentration of dsDNA was measured as described earlier and the DNA 
samples were stored at -20 °C until further use. 
 
 
Figure 5 | Map of the pGEM-T Easy Vector. The 3015bp linearized vector features a 3’-terminal 
thymidine at both ends. The vector allows for blue/white selection of recombinants, since it contains T7 
and SP6 RNA polymerase promoters flanking a multiple cloning region within the a-peptide coding region 
of the b-galactosidase enzyme (lacZ), in orange. The vector contains one ampicillin resistance gene (Ampr), 
in purple, and recognition sites for several restriction enzymes. Retrieved from manufacturer’s materials 
(Promega Corporation 2016). 
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5.2.4 Sequencing 
DNA sequencing was performed to confirm the presence or absence and type of angpt1 
mutation in animals of the Angpt1sa14264 and Turku lines, using SP6 or T7 RNA 
polymerase promoter sequencing primers (Oligomer, Helsinki, Finland) (Table 3), in 
separate reactions. The DNA template-primer cocktails were prepared according to the 
instructions of the sequencing service provider, FIMM Sequencing Unit, Helsinki, 
Finland, and included a sequencing reaction with the BigDye Terminator v3.1 Cycle 
Sequencing Kit (Applied Biosystems, Foster City, CA, USA), a reaction purification – 
dye terminator removal – with Optima DTR 96-Well filter plates (Edge Biosystems, 
Gaithersburg, MD, USA), electrophoresis with a 3730xl DNA Analyzer (Applied 
Biosystems, Foster City, CA, USA) and basecalling with Sequencing Analysis Software 
v5.2 (Applied Biosystems, Foster City, CA, USA). The quality of the sequencing 
chromatogram reports was evaluated with Sequence Scanner Software v1.0 (Applied 
Biosystems, Foster City, CA, USA) and the results were exported onto a presentation 
format. 
 
Table 3 | Sequencing primer information. 
Primer Primer sequence (5’ → 3’) 
SP6 CATACGATTTAGGTGACACTATAG 
T7 TAATACGACTCACTATAGGG 
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5.3 Mutation screening by high resolution melting 
 
5.3.1 Genomic DNA isolation 
To routinely genotype zebrafish and screen for the angpt1 mutation in the Angpt1sa14264 
line, genetic material was isolated from small portions of tail or fin tissue. Embryos and 
adults were briefly anesthetized by immersion in 0.5 or 0.9 mg/mL of MS-222 (Sigma-
Aldrich, St. Louis, MO, USA), respectively. The clippings were made with a clean 
scalpel. Tail clippings of individual 3 dpf embryos were placed in 15 µL of Lysis buffer 
(10 mM Tris pH 8.3, 50 mM KCl, 0.3% Tween-20, 0.3% NP40), in PCR tube strips. 
Alternatively, fin clippings of individual adults were placed in 50 µL of Lysis buffer, in 
PCR tube strips. All samples were lysed at 98 °C for 20 minutes and Proteinase K (Roche 
Diagnostics, Basel, Switzerland) was added in a final concentration of 0.4 mg/mL. The 
tail clips were incubated at 55 °C for 4 hours and the fin clips were incubated overnight 
at 55 °C to generate genomic DNA. To inactivate the Proteinase K (Roche Diagnostics, 
Basel, Switzerland), the reactions were incubated at 98 °C for 20 minutes. The DNA 
samples were stored at 4 °C until further use. 
 
 
5.3.2 High resolution melting analysis 
High resolution melting (HRM) analysis was performed to screen for the angpt1 mutation 
using a LightCycler 480 Instrument II (Roche Diagnostics, Basel, Switzerland). The 
amplification reactions were performed in LightCycler 480 Multiwell Plate 96 white 
plates (Roche Diagnostics, Basel, Switzerland), in 10 µL volumes containing 2.5 µL of 
genomic DNA, 0.15 µM of sa14264 primers (Oligomer, Helsinki, Finland) (Table 2), 2 
mM of MgCl2 and 5 µL of 2X LightCycler 480 HRM Master (Roche Diagnostics, Basel, 
Switzerland). All reactions were performed in duplicates. 
The PCR cycling included an initial denaturation at 95 °C for 10 minutes followed 
by 45 cycles of 10 seconds at 95 °C, 15 seconds at 60 °C and 20 seconds at 72 °C. The 
melting program included denaturation at 95 °C for 1 minute, renaturation at 40 °C for 1 
minute, and a melting cycle that consisted of a continuous fluorescent reading from 65 to 
90 °C at a rate of 25 acquisitions per °C. The program ended with a cooling step of 10 
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seconds at 40 °C. A LightCycler 480 Gene Scanning Software v1.5.1 (Roche Diagnostics, 
Basel, Switzerland) was used to perform Melt Curve Genotyping and Gene Scanning 
analyses. Data were normalized, temperature axes shifted and melting profile differences 
analyzed by interpreting the resulting difference plots. 
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5.4 Zebrafish transgenesis by Tol2kit 
 
Transgenic zebrafish lines with ectopic angpt1 overexpression driven by the ubiquitin 
(Ubi) and HuC promoters were generated by the Tol2kit method (Kwan et al 2007). Ubi 
drives a ubiquitous overexpression whereas HuC drives one that is neuronal-specific 
(Park et al 2000). A total of four plasmids were designed, with each of these promoters 
driving the expression of angpt1 and mCherry as an injection control. All constructs were 
tagged with a selective enhanced green fluorescent protein (EGFP) marker expressed in 
the heart. The plasmids and the Tol2 mRNA were co-injected into eggs of the Turku line 
at the one-cell stage. Approximately 2 nL of solution containing 25 to 50 ng/µL of 
plasmid DNA and 50 ng/µL of transposase was injected directly into the cytoplasm of the 
cell. The microinjection procedure was carried out using a PV830 Pneumatic PicoPump 
(World Precision Instruments, Sarasota, FL, USA) and a MN-153 Micromanipulator 
(Narishige, Tokyo, Japan). 
Adequate survival rates were achieved for both Ubi- and HuC-driven expression 
animals; Notwithstanding, aberrant morphology was present in approximately 30 to 40% 
of animals in each injection group. Selection of the animals for further experiments was 
based on two features: normal morphology and strong EGFP signal in the heart. The 
overexpression efficiency was examined by real-time quantitative polymerase chain 
reaction (RT-qPCR). 
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5.5 Zebrafish phenotyping 
 
5.5.1 Imaging of morphological features 
Zebrafish of the Angpt1sa14264 line were imaged at seven embryonic stages (Table 4), 
using a Leica DMi1 inverted microscope and a Leica MC120 HD camera (Leica 
Microsystems, Wetzlar, Germany). Animals 24 hpf and older were briefly anesthetized 
by immersion in 0.5 mg/mL of MS-222 (Sigma-Aldrich, St. Louis, MO, USA) during the 
imaging to minimize motor activity. 
 
Table 4 | Summary of zebrafish embryonic stages studied. 
Period Age Stage Real time post-fertilization (h) 
Zygote 0 hpf 1-Cell 0.2 
Gastrula 
5 hpf 50%-Epiboly 5.3 
10 hpf Bud 10 
Pharyngula 
24 hpf Prim-5 24 
36 hpf Prim-25 36 
Hatching 
48 hpf Long-pec 48 
72 hpf Protruding-mouth 72 
 
 
5.5.2 Imaging of vascular and non-vascular phenotypes 
Embryos of the Angpt1sa14264 line were grouped into KO or WT-like, at 36 hpf, based on 
anatomical and vascular features. Transgenic angpt1 overexpression individuals 
generated by the Tol2kit method were collected at 3 dpf, using the heart fluorescence 
intensity as a selective marker, and only those individuals with a strong heart fluorescent 
signal were selected for further imaging. For visualization and image acquisition of the 
live animals, PTU-treated embryos were briefly anesthetized by immersion in 0.5 mg/mL 
of MS-222 (Sigma-Aldrich, St. Louis, MO, USA) and embedded in 6% Methyl cellulose 
(Sigma-Aldrich, St. Louis, MO, USA). 
Videos of the cardiac rate were captured for 2 dpf Angpt1sa14264 and 3 dpf transgenic 
overexpression animals, at 50 fps. Furthermore, images of the whole body of each animal 
were acquired for measurements of brain and body length. All videos and images were 
taken with an Olympus IX70 inverted microscope (Olympus Corporation, Tokyo, Japan) 
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and a Hamamatsu ORCA-Flash4.0 v2 digital CMOS camera (Hamamatsu Photonics, 
Hamamatsu, Japan), processed with HCImage Software v4.2.0.31 (Hamamatsu 
Corporation, Bridgewater, NJ, USA) and analyzed with ImageJ Software v1.50i (public-
domain software). Heart rates were measured by manually counting each cardiac cycle – 
i.e. a heart contraction-relaxation event – for the full 20-second duration of the recordings. 
Beats per minute were calculated by multiplying the scores by a factor of 3. 
Measurements of brain and body length were determined by the ImageJ Software v1.50i 
(public-domain software) measuring tool. Pixel counts were converted to distances using 
a stage micrometer scale as a reference. 
 
 
5.5.3 Statistics 
Scatter plots of all measurements – body length, brain length and heart rate – were 
generated using GraphPad Prism Software v7.0b (GraphPad Software, San Diego, CA, 
USA) and the data were presented as the means ± standard error of the mean (SEM). The 
differences between the means were tested for significance using Unpaired t test between 
groups of Angpt1sa14264 fish. For the transgenic overexpression groups, significance was 
evaluated by the One-way Analysis of Variance (One-way ANOVA) for multiple 
comparisons followed by the Tukey post hoc test. A difference between two means was 
considered significant when P < 0.05 (*P < 0.05, **P < 0.01, ***P < 0.001). 
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5.6 Quantification of mRNA expression by real-time 
quantitative polymerase chain reaction 
 
5.6.1 RNA isolation and cDNA synthesis 
All independent RNA samples were isolated from pooled embryos or larvae, and reverse 
transcription was performed as described in section 5.2.1. 
 
 
5.6.2 Real-time quantitative polymerase chain reaction 
The specific gene transcripts were amplified by a LightCycler 480 Instrument II (Roche 
Diagnostics, Basel, Switzerland) with SYBR green chemistry. The RT-qPCR 
amplification reactions were performed in LightCycler 480 Multiwell Plate 96 white 
plates (Roche Diagnostics, Basel, Switzerland), in 10 µL volumes containing 2 µL of 
cDNA (diluted 1:4), 0.5 µM of primers (Table 5) and 5 µL of 2X LightCycler 480 SYBR 
Green I Master (Roche Diagnostics, Basel, Switzerland). All reactions were performed in 
duplicates. 
Thermocycling included an initial denaturation at 95 °C for 5 minutes followed by 
45 cycles of 10 seconds at 95 °C, 15 seconds at 60 °C and 20 seconds at 72 °C. The 
melting program included denaturation at 95 °C for 5 seconds, renaturation at 65 °C for 
1 minute, and a melting cycle that consisted of a continuous fluorescent reading from 65 
to 97 °C at a rate of 5 acquisitions per °C. The program ended with a cooling step of 10 
seconds at 40 °C. Tm Calling and Abs Quant/2nd Derivative Max analyses were generated 
by the LightCycler 480 Gene Scanning Software v1.5.1 (Roche Diagnostics, Basel, 
Switzerland). Crossing point (Cp) values were determined automatically for each 
individual sample and the mean Cp values were calculated for each pair of technical 
replicates. To correct for differences in both RNA quality and quantity as well as in the 
efficiency of cDNA synthesis between the samples, actin b1 (actb1) was used as a 
reference gene. 
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Table 5 | RT-qPCR primer information. 
Transcript 
Forward primer sequence 
(5’ → 3’) 
Reverse primer sequence 
(5’ → 3’) 
actb1 CGAGCAGGAGATGGGAACC CAACGGAAACGCTCATTGC 
angpt1 CGTCGCGGTTGGAAATTCAG AGGTCAGATTTCTCCGTCCG 
angpt2a TGATGCAGGACAACCCAGAT ATCCACCTCCATCTGTCTCCA 
angpt2b TGTGCGATCAGAGATGGAGC GGGAGACCTCCTGAGTTTGC 
apoea GAACAAAGCTAACTCCTATGCCA GTGAAGCACGAGACTGAACC 
apoeb AACGCCTGAACAAGGACACA GTATGGCTGGAAACGGTCCT 
epha4a TTCACCGCTGCTGGCTATAC TCTGGGACAACATTCCCTGC 
ephb4a TCGGACATTCGCCGGATATG CCAGTAACAAGCAGCGGAGA 
ephb4b GAGCACTCGACTCCTTCCTG TCATTCCAGACGCGATTCCA 
figf GAGCCTGTGCTGGTGAAAAT CTGCCATCCAGTCCCATATT 
gfap GAAGCAGGAGGCCAATGACTATC GGACTCATTAGACCCACGGAGAG 
itga5 TGTACGAGATTCAGGGCACG ACAGTCCACACTGGAGCAAG 
itgav ACTGTCTCAAGGCTAGTGGC GAACAGCACCCGTTTGATGG 
itgb1a AGCTTCATCTGCGAATGCGA CGACCCACACGACCCTTATT 
itgb1b TACGTCTCCCACTGCAAGAAC ACAGCCTTTTGCGGTGATCG 
nes GACAGCCTGATGTTGGATAGACAA CTGTCCAGCAAAGCTCTGTATGTT 
notch1a AGAGCCGGATTCAGCGGTC TTACAGGGACGTGGAGAACAAG 
pax2a CCGCGTTATTAAGTTCCCCT TGGCGTATCCATCTTCAATCC 
pax2b TACCTGGATATCCACCTCAC GAGCCTCTGGATGCACTATA 
pax5 GTGGCAGTGACGCAGGTTTCT GCTGTTCTTCATCTCCTCCAA 
pcna ACGCCTTGGCACTGGTCTT CTCTGGAATGCCAAGCTGCT 
sox2 CCTATTCGCAGCAAAGCACG GGAATGAGACGACGACGTGA 
sox10 AGGGTCACCATTGGGTGATG TCGCCTGATTTTCCTCCCTG 
tek TCAACACAGAGCCCTACAGC GTCCAGTCGCACCAGCG 
th GACGGAAGATGATCGGAGACA CCGCCATGTTCCGATTTCT 
th2 CTCCAGAAGAGAATGCCACATG ACGTTCACTCTCCAGCTGAGTG 
tie1 GGCTCTTCTGGCCCTCTTTT TTGGTCGTCGGGTAAGTGTG 
vegfaa AAAAGAGTGCGTGCAAGACC GACGTTTCGTGTCTCTGTCG 
vegfab TGTTGGTGGAAATTCAGCAG CACCCTGATGACGAAGAGGT 
vegfba TGGGAGACGAATCACCTCTT GCTGCACAAGTTCATGCTTC 
vegfc CGACAGCAGCACTCAATCAT CTGACACGTCTCCTCATCCA 
wnt1 ACGCTATCTGACCAACCTGC GGATCCAGACATCCCGTGAC 
wnt2bb GTGGCGCTAAGGAGTGGATT TATACGAACGCTGCCTCACG 
wnt10b CTCGTGATATACACGCTCGCA CCATGGCACTTGCACTTTCTC 
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5.6.3 Statistics 
The gene expression data were normalized using the ratio of the target cDNA 
concentration to that of actb1, due to its wide use and relative stability throughout the 
developmental stages of zebrafish (Hu et al 2016). To analyze relative changes in gene 
expression, the Double delta CT (2-ΔΔCT) method was applied (Livak & Schmittgen 2001). 
Graphical representations and statistical analyses of the RT-qPCR data were generated 
using GraphPad Prism Software v7.0b (GraphPad Software, San Diego, CA, USA). The 
data were presented as the means ± standard deviation (SD) and the differences between 
the means were tested for significance using the One-way ANOVA for multiple 
comparisons followed by the Tukey post hoc test. A difference between two means was 
considered significant when P < 0.05 (*P < 0.05, **P < 0.01, ***P < 0.001). 
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5.7 Whole-mount in situ hybridization 
 
5.7.1 Sample preparation 
Zebrafish embryos of the Turku and Angpt1sa14264 lines were raised in E3 medium 
whereas angpt1 overexpression embryos were raised in E3 medium in the presence of 
PTU to inhibit pigmentation. For 24 hpf fish or older, the chorions were mechanically 
removed and the animals were immediately sacrificed. For animals younger than 24 hpf, 
the chorions were removed just after the fixation step. Zebrafish from all different lines 
at different stages were fixed in 4% PFA in PBS overnight at 4 °C with gentle agitation. 
The fixative was changed the following day to 100% methanol and the samples were 
stored at -20 °C until further use. 
 
 
5.7.2 Probe synthesis 
DIG-labeled sense (S) and antisense (AS) riboprobes were synthesized from existing 
plasmids or by using specific primers to generate new clones (Table 6). Specific gene 
regions were amplified from 1, 2, or 3 dpf Turku line cDNA, according to their expected 
expression either during the early or late embryonic stage. These inserts were integrated 
into the pGEM-T Easy Vector (Promega, Madison, WI, USA) (Figure 5) and competent 
bacteria of the DH5α strain (Invitrogen, Carlsbad, CA, USA) were transformed to 
exponentially replicate the constructs, as described previously. The plasmids were 
isolated and purified from the bacterial cultures by a QIAprep Spin Miniprep Kit (Qiagen, 
Hilden, Germany). The concentration of dsDNA was measured by a BioPhotometer 
(Eppendorf, Hamburg, Germany) and the DNA samples were stored at -20 °C until 
further use. 
The restriction enzyme digestion reactions (Table 7) were performed in eppendorfs, 
in final volumes of 40 µL containing 2 µg of plasmid DNA, 5 µL of restriction buffer and 
4 µL of restriction enzyme. The reactions were incubated for 2.5 hours at 37 °C. Gel 
electrophoresis was performed with 2 µL of the reaction product, as previously described, 
and the DNA integrity was assessed through imaging of the gel under UV light exposure. 
The reaction products were purified by a MinElute PCR Purification Kit (Qiagen, Hilden, 
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Germany) and the concentration of dsDNA was measured by a BioPhotometer 
(Eppendorf, Hamburg, Germany). The RNA was labelled with DIG-UTP using a DIG 
RNA Labeling Kit (Roche Diagnostics, Basel, Switzerland), following in vitro 
transcription with SP6 or T7 RNA polymerases (Table 7). 
 
Table 6 | PCR primer information for WISH probe synthesis. 
Transcript 
Forward primer sequence 
(5’ → 3’) 
Reverse primer sequence 
(5’ → 3’) 
angpt1 Primer sequences obtained from reference (Chen et al 2015) 
angpt2a CAGACAGCAGAGCAATCACG CCACAAGCATCAAACCACCA 
angpt2b GGAAAGGAAGCTGGAGACCC ACCCCTGGCATGGAGACTAT 
apoeb Clone obtained as a gift from Dr. Francesca Peri 
itgb1b GAACGCTTACCTCCGACTCC TCCCGCTCTTTGCAGTGATT 
nes GTACCAGATGCTAGAGCTGAACCACCGCCTT GCATCTGCCTCTTGATCCTCGTGCTCTCCAG 
notch1a Primer sequences obtained from reference (Chen et al 2015) 
tek GGACACTCAGCGACCAGCTT GAGCAGTCGATTCCTGCGTA 
th Primer sequences obtained from reference (Chen et al 2009b) 
tie1 TGCACAGTACATCTTGGATGG TTATTCAGTTCCCCCTGCCTG 
wnt1 TTGGTTAACTTTGCCCTTTCAGA TATGCGCTGGGTTTTCTGGT 
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Table 7 | Restriction enzyme and RNA polymerase information for WISH probe synthesis reactions. 
Riboprobe Restriction enzyme RNA polymerase 
angpt1 AS BglII SP6 
angpt2a AS HindIII SP6 
angpt2a S SalI T7 
angpt2b AS NcoI SP6 
angpt2b S SalI T7 
apoeb AS HindIII T7 
itgb1b AS NcoI SP6 
itgb1b S SalI T7 
nes AS NcoI SP6 
notch1a AS XbaI T7 
tek AS EcoRV SP6 
th AS NcoI SP6 
tie1 AS ApaI SP6 
tie1 S SalI T7 
wnt1 AS SalI T7 
wnt1 S NcoI SP6 
 
 
5.7.3 In situ hybridization 
The whole-mount in situ hybridization (WISH) reactions were carried out as reported 
earlier (Thisse & Thisse 2008). The protocol was slightly modified to improve the sample 
quality and the hybridization efficiency (Table 8). An alkaline phosphatase-conjugated 
antibody (Roche Diagnostics, Basel, Switzerland) against DIG was used to target the 
DIG-labeled RNA. The staining reactions were induced by a solution containing NBT 
and BCIP (Roche Diagnostics, Basel, Switzerland). The stained samples were mounted 
between glass slides with 80% glycerol. Brightfield images of samples 24 hpf and earlier 
were taken by a Leica DMi1 inverted microscope and a Leica MC120 HD camera (Leica 
Microsystems, Wetzlar, Germany) whereas those of samples later than 24 hpf were taken 
by a Leica DM IRB inverted microscope with a Leica DFC480 camera (Leica 
Microsystems, Wetzlar, Germany). All original images and z-stacks were processed with 
Leica Application Suite Software v4.6 (Leica Microsystems, Wetzlar, Germany). 
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Table 8 | WISH protocol optimization. 
Protocol step Procedure 
Permeabilization 
0, 5 and 10 hpf samples: 30 seconds 
24 hpf samples: 10 minutes 
36 hpf samples: 15 minutes 
72 hpf samples: 25 minutes 
Prehybridization 62 °C, 3.5 h 
Hybridization 75 ng of RNA probe, 62 °C 
High-stringency washing 62 °C 
Preincubation 3.5 h 
Incubation 1:5000 antibody dilution 
Stop reaction 
4x quick wash with PBS 0.1% Tween-20, 10-minute incubation with 
100 mM glycine (pH 2.0) 0.1% Tween-20, 4x quick wash with PBS 
0.1% Tween-20, 2x 10-minute wash with PBS 0.1% Tween-20 
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6 RESULTS 
 
6.1 Expression of angiocrine factors during zebrafish 
embryogenesis 
The spatiotemporal expression of the angiocrine factors angpt1, angpt2a, angpt2b, tek 
and tie1 throughout zebrafish embryogenesis was studied in seven stages of the Turku 
line: 1-cell (0.2 h), 50%-epiboly (5.3 h), bud (10 h), prim-5 (24 h), prim-25 (36 h), long-
pec (48 h) and protruding-mouth (72 h). The results revealed major differences in their 
relative abundance and distribution during the early zebrafish development (Figure 6). 
Angpt1 and tek were both expressed in the yolk and the yolk syncytial layer, at the 
1-cell stage (Figure 6-a). This region undergoes dynamic changes in the first hours post-
fertilization (Schier 2001) (Carvalho & Heisenberg 2010), substantiating the importance 
of Angpt1/Tek signaling from a very early stage, in the morphogenesis and patterning of 
tissues that will later form the nervous system and the surrounding tissues. The 
distribution of angpt1 and tek expression is likely maternally-inherited, suggesting an 
essential role in early development. All the angiocrine factors showed similar expression 
patterns, distributing diffusely across the blastoderm at the 50%-epiboly stage (Figure 6-
a). The angpt1 and especially tek expression patterns intensified but remained uniform in 
the ectoderm and mesoderm at the bud stage. The ectoderm layer comprises the 
neuroectoderm, the major contributor to the tissues of the future nervous system (Driever 
1995). 
At the prim-5 stage, the primary blood vessel network is adequately formed. The 
heart starts beating shortly before this stage, initiating the blood circulation. At this stage, 
angpt1 showed a robust distribution in the heart, eyes, brain, ventral part of the trunk and 
distinctively in the tail. The other factors expressed mainly in the eyes and brain, with tek 
and tie1 being expressed also in the posterior part of the trunk and tail (Figure 6-a). 
Coincidently with the stabilization of the vascular system by 1 dpf, angpt1 and tek reached 
their peak expression at this stage (Figure 6-b). The expression of angpt2a and angpt2b, 
persisted at low levels throughout the first days post-fertilization whereas the expression 
of the orphan receptor tie1 reflected that of angpt1 across the developmental stages 
represented (Figure 6-b). The expression levels for all the genes remained fairly stable 
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through the prim-25, long-pec and protruding-mouth stages, indicating an equilibrium of 
the angiocrine factor signaling after 2 dpf (Figure 6-b). 
 
 
Figure 6 | Expression of angiocrine factors in zebrafish embryonic stages. a, WISH results in ages 0 to 
24 hpf (n = 5 per stage). Arrowheads indicate expression in the brain (B), blastoderm (BD), 
endoderm/mesoderm (ED/MD), eye (E), heart (H), tail (Ta), trunk (Tr), yolk (Y) and yolk syncytial layer 
(YSL). Scale bars, 200 µm. Sense controls for angpt2a, angpt2b and tie1 are shown in Figure S1-a 
(Appendix A). b, RT-qPCR results in whole embryos aged 0 to 72 hpf (n = 3 per stage). Data shown in 
mean ± SD. 
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6.2 Characterization of the Angpt1sa14264 line 
 
6.2.1 Genotypes of Angpt1sa14264 fish 
The Angpt1sa14264 line was the product of reverse genetics by mutagenesis, using the 
TILLING method (Kettleborough et al 2013). The resulting mutation is a C to T 
substitution leading to a nonsense mutation in Q261 to a stop codon. This mutation 
prevents the translation of the fibrinogen C-terminal domain whereby Angpt1 binds to 
the Tek receptor. Sequencing of Angpt1sa14264 WT, HET and KO fish confirmed the 
presence of two wild-type alleles (+/+) in the WT samples and two mutated alleles (-/-) 
in the KO samples. As expected, the HET samples showed a combination of wild-type 
and mutated alleles. The allele sequences are shown in the form of chromatograms 
(Figure 7-a). 
Angpt1sa14264 embryos could be genotyped the earliest at 3 dpf. The HRM curve 
analysis was applied to routinely determine the genotypes of adult and embryonic 
zebrafish. Angpt1sa14264 embryos of the same shoal regularly followed a Mendelian 
distribution, where approximately 25% inherited +/+ alleles (WT), 50% inherited +/- 
alleles (HET) and 25% inherited -/- alleles (KO) (Figure 7-b). 
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Figure 7 | Genotypes of Angpt1sa14264 fish. a, Wild-type and mutated allele chromatograms from 
sequencing of WT, HET and KO individuals. The amino acid glutamine (Q) in the wild-type sequence is 
replaced by a stop codon (STOP) in the mutated sequence. b, Melting curves of WT (green), HET (blue) 
and KO (red) obtained from HRM analysis. 
 
 
6.2.2 Phenotypes of embryonic Angpt1sa14264 fish 
Phenotyping of the Angpt1sa14264 line was based on anatomical and physiological features 
(Figure 8). During the first day of development, no evident morphological differences 
could be found among individuals of the same shoal (Figure 8-a). The first phenotypical 
consequences of the angpt1 mutation became evident at 36 hpf, when approximately 25% 
of all embryos of the same shoal showed a visibly slower heart rate as well as impaired 
blood circulation, most notably in the blood vessels of the trunk and tail (Figure 8-b). The 
same features were observed at 48 hpf and intensified by 72 hpf, again with approximately 
25% of the shoal exhibiting a much slower heart rate and blood circulation, and smaller 
head and body sizes than other siblings. Moreover, a considerable proportion of the 
individuals showing aberrant cardiovascular function also displayed some degree of heart 
edema at 72 hpf. 
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All the individuals with aberrant morphology and cardiovascular function died by 
5 dpf, as an effect of the severe developmental abnormalities caused by the absence of 
functional Angpt1. For further experiments on the role of Angpt1 in zebrafish 
embryogenesis, 36 hpf individuals showing a markedly defective cardiovascular function 
were considered KO and those with intact cardiovascular function were considered WT-
like siblings. 
 
 
Figure 8 | Morphology and general phenotypical differences of WT-like and KO Angpt1sa14264 fish. a, 
Live imaging of grouped and individual embryos of ages 0 to 24 hpf. Scale bars, 200 µm. b, Live imaging 
of grouped and individual embryos of ages 36 to 72 hpf. Arrowheads identify the KO fish in the group 
images; and indicate the phenotypical findings in the individual fish images: blood circulation (bc), heart 
beat (hb) and pericardial edema (pe). Scale bars, 200 µm. 
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In addition to the general morphology, lengths of the body and brain, and the heart 
rate were measured in groups of 2 dpf WT-like and KO individuals (Figure 9). The 
measurements of body and brain length were obtained in pixels and converted to 
millimeters and micrometers, respectively. The number of heart beats per minute (bpm) 
was estimated from the number of beats calculated from 20-second videos (Figure 9-d). 
In the Angpt1sa14264 KO group, the embryos had significantly shorter bodies, but no 
clear difference was found in the length of brains between the KO and WT-like groups 
(Figure 9-a). The brains of Angpt1sa14264 KO embryos showed a substantially larger 
variation in length than the WT-like siblings, implying a bigger disparity in brain 
phenotypes as an effect of the absence of Angpt1 (Figure 9-b). After 24 hpf, the 
development of zebrafish can be approximately inferred from the head-trunk angle 
(Kimmel et al 1995). As the embryo develops into larva, the head-trunk angle increases 
until it reaches 180° at approximately 5 dpf. During this period, the brain shortens in 
length as it increases in overall volume. For this reason, measurements of the zebrafish 
embryonic brain are affected by multiple factors that pose some challenges to the 
interpretation of such assessments. The analysis of the heart function revealed a robustly 
decreased heart rate in KO embryos compared to the WT-like siblings, reinforcing the 
fundamental role of Angpt1 in the cardiovascular system (Figure 9-c). 
 
 43 
 
Figure 9 | Measurements of body length, brain length and heart rate of 2 dpf WT-like and KO 
Angpt1sa14264 fish. a, b, Measurements of body length, in millimeters (mm), and brain length, in 
micrometers (µm), from single images of individuals phenotyped as WT-like or KO (n = 9 per group), 
based on blood flow speed. Data shown in mean ± SEM. **P < 0.01. c, Measurement of heart rate, in beats 
per minute (bpm), from videos of beating hearts of individuals phenotyped as WT-like or KO (n = 9 per 
group), based on blood flow speed. Data shown in mean ± SEM. ***P < 0.001. d, Measurement procedure 
for body and brain length, and location of the heart in 2 dpf zebrafish. Scale bars, 200 µm (body and brain), 
50 µm (heart). 
 
 
6.2.3 Gene expression screening in Angpt1sa14264 fish 
Quantification of relative mRNA levels was performed in samples of 3 dpf Angpt1sa14264 
fish (Figure 10 and Table 9). Individuals were genotyped by HRM and pooled into groups 
of WT, HET and KO. 
Angpt1 and tek showed similar expression trends with a robustly lower expression 
in the KO compared to both WT and HET groups (Figure 10-a and 10-b). A homozygous 
nonsense mutation coding for a premature stop codon will trigger an endogenous process 
known as nonsense-mediated mRNA decay (NMD) (Wittkopp et al 2009). Although 
NMD pathways clear the cells from aberrant mRNA in a time-dependent manner, some 
aberrant mRNA will likely still be translated into non-functional protein (Vicente-Crespo 
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& Palacios 2010). Thus, angpt1 expression in the KO fish is likely attributed to the 
aberrant mRNA present in the cells at the time of RNA isolation. Other angiogenic factors 
were also significantly affected by the loss of functional Angpt1 (Table 9). Angpt2a and 
vegfaa, important factors for vascular remodeling, were upregulated in the KO fish, as 
was figf, the zebrafish ortholog of human VEGFD. In contrast, vegfba was downregulated 
in the KO fish. Of the integrins studied, itgb1b was the only one found to be significantly 
upregulated in the KO fish (Figure 10-c and Table 9). 
Wnt1, a regulator of cell fate and patterning during embryogenesis, was 
dramatically downregulated in the KO fish (Figure 10-d). Wnt2bb and wnt10b, regulators 
of cell growth and differentiation, were up and downregulated in the KO fish, respectively 
(Table 9). Likewise, sox2 expression was robustly decreased in the KO fish; However, 
the expression of sox10 and the Eph receptors included in this analysis did not change 
significantly between groups (Table 9). The early neuronal markers nes and notch1a were 
both significantly downregulated in the KO fish (Figure 10-e and 10-f). Other important 
markers such as pax5 and pcna were also significantly downregulated in the KO fish 
(Table 9). The glial markers apoeb and gfap showed a modest upregulation in the KO 
fish although differences in gfap expression were only statistically significant in KO fish 
compared to HET, but not WT siblings (Figure 10-g and Table 9). Th, a marker of 
dopaminergic neurons, was downregulated in the angpt1 KO fish (Figure 10-h). 
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Figure 10 | Expression screening of relevant genes in 3 dpf Angpt1sa14264 fish. a, b, c, d, e, f, g, h, 
Expression of relevant genes relative to the expression of actb1 in groups of individuals genotyped as WT, 
HET or KO (n = 3 replicates per group). Data shown in mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001. 
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Table 9 | Summary of additional RT-qPCR expression screening results in 3 dpf Angpt1sa14264 fish. 
Biological process Gene KO vs WT KO vs HET HET vs WT 
Angiogenesis 
angpt2a up * up * ns 
angpt2b ns ns ns 
figf up ** up * ns 
itga5 ns ns ns 
itgav ns ns ns 
itgb1a ns ns ns 
tie1 ns ns ns 
vegfaa up ** up *** ns 
vegfab ns ns ns 
vegfba down ** down * ns 
vegfc ns ns ns 
Neural patterning 
epha4a ns ns ns 
ephb4a ns ns ns 
ephb4b ns ns ns 
sox2 down *** down *** ns 
sox10 ns ns ns 
wnt2bb up * up * ns 
wnt10b down *** down *** ns 
Neuronal and glial 
development 
apoea ns ns ns 
gfap ns up * ns 
pax2a ns ns ns 
pax2b ns ns ns 
pax5 down ** down ** ns 
pcna down *** down *** ns 
th2 ns ns ns 
*P < 0.05, **P < 0.01, ***P < 0.001, ns: non-significant. The mean and SD values are shown in Table S1 
(Appendix B). 
 
 
6.2.4 Gene expression patterns in Angpt1sa14264 fish 
The RT-qPCR results guided further investigation of some of the differentially expressed 
genes in angpt1 mutants. At 3 dpf, the Angpt1sa14264 KO fish exhibited malformations 
ultimately leading to lethality by 5 dpf. Genotyping of single embryos was impractical at 
stages earlier than 3 dpf; Therefore, embryo classification into WT-like or KO was based 
on the vascular profiles of 36 hpf embryos, described in section 6.2.2. The spatiotemporal 
 47 
expression profiles of relevant genes were assessed by hybridization of whole 36 hpf 
Angpt1sa14264 embryos with suitable probes for angpt1, tek, itgb1b, wnt1, nes, notch1a, 
apoeb and th (Figures 11 and 12). 
Angpt1 in the WT-like fish was highly expressed in the aortic arches and pronephric 
region above the yolk as well as along the perivascular caudal artery and vein regions. It 
also appeared diffusely in the midbrain-hindbrain boundary (Figure 11-a). In the KO 
embryos, angpt1 was nearly wiped out in the trunk and tail although it appeared in the 
aortic arches. As in the expression screening, angpt1 expression in the KO embryos is 
likely due to aberrant mRNA partially compatible with the probe’s sequence or residual 
expression of maternal angpt1. Tek expression showed only modest differences between 
WT-like and KO individuals at this stage (Figure 11-b). It was equally expressed in the 
heart and aortic arches, but more intense at the midbrain-hindbrain boundary in the KO 
embryos, in addition to being expressed exclusively in the perivascular caudal vein region 
in the tail of the WT-like siblings. 
Itgb1b was broadly expressed in the whole embryo, but especially in the midbrain, 
hindbrain, aortic arches, pronephric region, notochord and perivascular caudal artery and 
vein regions (Figure 11-c). Notably, the expression intensity was higher at the midline in 
the KO embryos than in the WT-like siblings. The expression pattern of wnt1 exposed 
the sites of active neural patterning at this stage of development (Figure 11-d). Strong 
expression was found from the epiphysis along the dorsal domain of the midbrain and 
dorsal and ventral domains of the midbrain-hindbrain boundary in both WT-like and KO 
embryos. However, wnt1 expression was reduced at the rhombomere edges and missing 
altogether from the posterior edge of the cerebellum in the KO embryos. 
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Figure 11 | Spatiotemporal expression of genes involved in angiogenesis and patterning processes in 
36 hpf Angpt1sa14264 fish. a, b, c, d, Representative images of the distribution of differentially-expressed 
genes identified from the expression screening. Images of individuals phenotyped as WT-like or KO (n = 
5 per group), based on blood flow speed. Arrowheads indicate expression in the aortic arches (aa), caudal 
perivascular region (cpv), cerebellum (c), epiphysis (e), heart (h), hindbrain (hb), midbrain (mb), midbrain-
hindbrain boundary (mhb), midline (ml), notochord (nc), pronephric region (pn) and rhombomeres (r). 
Scale bars, 200 µm. Sense controls for itgb1b and wnt1 are shown in Figure S1-b (Appendix A). 
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The early neuronal markers nes and notch1a were both widely expressed in the 
developing CNS (Figure 12-a and 12-b). In the case of nes, expression was more intense 
in the hindbrain, especially in the hindbrain ventricle and the spinal cord of the WT-like 
siblings than in the same structures in the KO embryos (Figure 12-a). In addition, nes was 
nearly absent from the ventral midbrain and weaker in the midbrain-hindbrain region in 
the KO embryos. On the other hand, notch1a showed identical expression patterns in 
comparable intensity between WT-like and KO embryos, being strongly expressed 
throughout the brain and spinal cord (Figure 12-b). 
Apoeb was mostly expressed in the yolk sac and in the yolk sac extension, owing 
to the lipidic composition of the yolk (Figure 12-c). Expression was also present in the 
caudal neural tube and faintly in the eyes and apical ectodermal ridge of the tail fin, but 
no significant differences were found between WT-like and KO embryos. Characteristic 
th expression was detected in the olfactory bulb dopaminergic cluster in the forebrain, in 
the diencephalic catecholaminergic cluster in the midbrain and in the locus coeruleus in 
the hindbrain (Figure 12-d). However, the expression pattern of th in the KO embryos 
was not significantly different from that of the WT-like siblings. 
 
 50 
 
Figure 12 | Spatiotemporal expression of early and mature neuronal markers in 36 hpf Angpt1sa14264 
fish. a, b, c, d, Representative images of the distribution of differentially-expressed genes identified from 
the expression screening. Images of individuals phenotyped as WT-like or KO (n = 5 per group), based on 
blood flow speed. Arrowheads indicate expression in the apical ectodermal ridge (aer), diencephalic 
catecholaminergic cluster (dcc), eyes (e), forebrain (fb), hindbrain (hb), locus coeruleus (lc), midbrain (mb), 
neural tube (nt), olfactory bulb dopaminergic cluster (odc), spinal cord (sc), yolk sac (ys) and yolk sac 
extension (yse). Scale bars, 200 µm. 
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6.3 Characterization of the transgenic overexpression model 
 
6.3.1 Phenotypes of transgenic overexpression fish 
Transgenic overexpression of angpt1 was accomplished using two promoters: Ubi and 
HuC. The Ubi promoter generates ubiquitous expression of the gene of interest in all body 
tissues whereas the HuC promoter drives a neuronal-specific expression of the gene of 
interest. The Turku WT embryos injected with the overexpression cocktails at the 1-cell 
stage were raised until 3 dpf and screened for assessment of the morphology and intensity 
of the fluorescent marker, EGFP (Figure 13). 
 
 
Figure 13 | Ectopic expression of angpt1 and mCherry by the Ubi and HuC promoters in 3 dpf injected 
Turku WT. All four constructs shown included an EGFP marker expressed in the heart. The EGFP signal 
(green) was used to evaluate the success of angpt1 overexpression whereas the mCherry signal (red) was 
used as an injection control. All further experiments were conducted in parallel with uninjected WT siblings 
as controls (not shown in the figure). Scale bar, 200 µm. 
 
Heart rate, body and brain length were measured for both Ubi- and HuC-driven 
transgenic lines of angpt1 overexpression (Figure 14). Body and brain length 
measurements did not show statistically significant changes between either of the 
overexpression groups and the uninjected control group (Figure 14-a and 14-b). In 
contrast, the heart rate of both overexpression groups was very significantly elevated 
compared to the uninjected group (Figure 14-c). Interestingly, neuronal-specific 
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overexpression, by the HuC promoter, produced a matching effect in heart rate to that of 
the ubiquitous overexpression, by the Ubi promoter. As done for the Angpt1sa14264 line, 
body and brain measurements were obtained in pixels and converted to millimeters and 
micrometers, respectively. The number of heart beats per minute was estimated from the 
number of beats calculated from 20-second videos (Figure 14-d). 
 
 
Figure 14 | Measurements of body length, brain length and heart rate of 3 dpf transgenic angpt1 
overexpression fish. a, b, Measurements of body length, in millimeters (mm), and brain length, in 
micrometers (µm), from single images of Ubi:angpt1, HuC:angpt1 and uninjected individuals (n = 9 per 
group). Data shown in mean ± SEM. c, Measurement of heart rate, in beats per minute (bpm), from videos 
of beating hearts of Ubi:angpt1, HuC:angpt1 and uninjected individuals (n = 9 per group). Data shown in 
mean ± SEM. ***P < 0.001. d, Measurement procedure for body and brain length, and location of the heart 
in 3 dpf zebrafish. Scale bars, 200 µm (body and brain), 50 µm (heart). 
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6.3.2 Gene expression screening in transgenic overexpression fish 
To assess the outcome of gain-of-function of Angpt1 in many of the genes previously 
analyzed in the Angpt1sa14264 line, a transgenic line of Ubi-driven overexpression was 
used to screen for gene expression changes in 3 dpf samples of Ubi:angpt1 fish compared 
to Ubi:mCherry controls and uninjected controls (Figure 15). 
A nearly 40-fold increase in angpt1 expression in the Ubi:angpt1 compared to both 
Ubi:mCherry and uninjected groups confirmed the effectiveness of the transgenic 
overexpression (Figure 15-a). Nonetheless, this expression increase in angpt1 did not 
have an effect in tek expression or in most other genes related to angiogenesis (Figure 15-
b and Table 10). Remarkably, tie1 expression followed the same trend as angpt1, showing 
a statistically significant increase in the Ubi:angpt1 compared to both control groups 
(Table 10). The expression of two integrins, itgb1b and itga5, was slightly increased in 
the Ubi:angpt1 compared to the injected Ubi:mCherry group, but not the uninjected 
group (Figure 15-c and Table 10). This was likely a nonspecific effect of mCherry 
expression since the mean expression of both integrins between Ubi:angpt1 and 
uninjected groups was very similar. Differences between groups for wnt1 and other neural 
patterning genes were not statistically significant (Figure 15-d and Table 10). 
Besides its impact on notch1a expression, Ubi-driven angpt1 overexpression did 
not elicit a significant effect on other early neuronal markers (Figure 15-e and Table 10). 
Notch1a was only modestly increased in the Ubi:angpt1 compared to the Ubi:mCherry 
group, but showed an increased trend compared to both Ubi:mCherry and uninjected 
groups (Figure 15-f). The astroglial marker gfap was significantly decreased in the 
Ubi:angpt1 compared to the uninjected group although the same trend was seen in the 
Ubi:mCherry compared to the uninjected group, suggesting that the decrease in gfap 
expression was not specific to angpt1 overexpression (Table 10). No other differences 
were found in the expression of the mature neuronal markers, including those of apoeb 
and th (Table 10, Figure 15-g and 15-h). 
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Figure 15 | Expression screening of relevant genes in 3 dpf Ubi-driven transgenic overexpression fish. 
a, b, c, d, e, f, g, h, Expression of relevant genes relative to the expression of actb1 in groups of Ubi:angpt1, 
Ubi:mCherry and uninjected individuals (n = 3 replicates per group). Data shown in mean ± SD. *P < 0.05, 
***P < 0.001. 
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Table 10 | Summary of additional RT-qPCR expression screening results in 3 dpf Ubi-driven 
transgenic overexpression fish. 
Biological 
process 
Gene 
Ubi:angpt1 vs 
Uninjected 
Ubi:angpt1 vs 
Ubi:mCherry 
Ubi:mCherry vs 
Uninjected 
Angiogenesis 
angpt2a ns ns ns 
angpt2b ns ns ns 
figf ns ns ns 
itga5 ns up * ns 
itgav ns ns ns 
itgb1a ns ns ns 
tie1 up ** up ** ns 
vegfaa ns ns ns 
vegfba ns ns ns 
Neural patterning 
epha4a ns ns ns 
sox2 ns ns ns 
sox10 ns ns ns 
wnt2bb ns ns ns 
wnt10b ns ns ns 
Neuronal and glial 
development 
apoea ns ns ns 
gfap down * ns down ** 
pax5 ns ns ns 
pcna ns ns ns 
th2 ns ns ns 
*P < 0.05, **P < 0.01, ns: non-significant. The mean and SD values are shown in Table S2 (Appendix B). 
 
 
6.3.3 Gene expression patterns of angpt1 and notch1a in transgenic 
overexpression fish 
Overexpression by the Ubi and HuC promoters granted a closer look at the ubiquitous 
and neuronal-specific effects of increased angpt1 expression, respectively. Angpt1 was 
expressed in the heart, aortic arches and primary head sinus of the uninjected siblings, as 
it was also for both Ubi- and HuC-driven overexpression fish (Figure 16). However, the 
expression in the aortic arches and primary head sinus was more intense in Ubi:angpt1 
and HuC:angpt1 compared to the uninjected controls. Additionally, angpt1 expression 
was present in the vessels of the yolk sac in samples of both overexpression groups, while 
it was absent in the uninjected siblings. Furthermore, exclusively in the Ubi:angpt1 fish, 
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angpt1 expression was more robust in the heart, while it appeared irregularly along the 
trunk. 
 
 
Figure 16 | Spatiotemporal expression of angpt1 in 3 dpf transgenic angpt1 overexpression fish. 
Representative images of the distribution of angpt1 in Ubi- and HuC-driven angpt1 overexpression as well 
as in uninjected controls (n = 5 per group). Arrowheads indicate expression in the aortic arches (aa), heart 
(h), primary head sinus (phs), trunk (t) and yolk sac (ys). Scale bars, 200 µm. The expression pattern of 
angpt1 in the Ubi:mCherry injected controls is shown in Figure S1-c (Appendix A). 
 
The expression pattern of notch1a in an angpt1 overexpression setting was of 
particular interest, since it was the only early neuronal marker for which an expression 
change was detected in the expression screening. Notch1a expression was stronger in the 
primary head sinus of Ubi:angpt1 and HuC:angpt1 fish in comparison with the uninjected 
siblings, but showed similar intensity between all groups in the eyes, aortic arches, 
anterior cardinal vein and vessels of the yolk sac (Figure 17). In the brain, notch1a was 
distributed in the subpallium, pallium, habenula, tectum opticum, cerebellar plate, 
medulla oblongata, olfactory bulb, dorsal thalamus, lateral tectal proliferation zone, 
octaval and vagal ganglia, rhombic lip, medial optic tectum and midbrain-hindbrain 
boundary. Although a slightly stronger expression of notch1a was detected in the most 
dorsal brain areas, angpt1 overexpression induced far more significant differences in 
notch1a expression in the primary head sinus, compared to the uninjected controls. 
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Figure 17 | Spatiotemporal expression of notch1a in 3 dpf transgenic angpt1 overexpression fish. 
Representative images of the distribution of notch1a in Ubi- and HuC-driven angpt1 overexpression as 
well as in uninjected WT controls (n = 5 per group). Domains of expression identified in the cerebellar 
plate (CeP), dorsal thalamus (DT), habenula (Ha), lateral tectal proliferation zone (l), medial optic tectum 
(m), midbrain-hindbrain boundary (MHB), medulla oblongata (MO), olfactory bulb (OB), octaval ganglion 
(OG), pallium (P), rhombic lip (RL), subpallium (S), tectum opticum (TeO) and vagal ganglion (VG). Scale 
bars, 200 µm (left and middle columns), 100 µm (right column). The expression pattern of notch1a in the 
Ubi:mCherry injected controls is shown in Figure S1-c (Appendix A). 
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7 DISCUSSION 
 
Angiogenesis and neurogenesis are juxtaposed biological processes in the development 
of vertebrate organisms. Indeed, vessel navigation and the patterning of the vascular 
network have been shown to rely on guidance signals originating from the developing 
nervous system. The physical co-dependence of nerves and vessels complies with the 
existence of common regulatory mechanisms shared between the two (Autiero et al 2005, 
Eichmann et al 2005). 
The angiocrine ANGPT-TEK system has established roles in angiogenesis and 
vascular homeostasis. Yet, preceding work by several authors has gathered strong 
evidence of its importance in neurogenesis and regulation of NSC niche responses 
(Androutsellis-Theotokis et al 2010, Bai et al 2009, Rosa et al 2010, Ward et al 2005). At 
the molecular level, a direct role for ANGPT1 in neurogenesis remains unclear despite its 
potential as a candidate for adjuvant therapy of brain vascular injury, as some studies 
have suggested (Kawamura et al 2014, Yan et al 2014, Zhao et al 2010). 
The zebrafish is an excellent model organism for the study of developmental 
processes. Despite the evident anatomical differences between zebrafish and humans, 
genetic homology is relatively high and the developmental pathways regulating the 
physiology of the cardiovascular and nervous systems are widely conserved between the 
two species (Kalueff et al 2014, Larrivee et al 2009). 
The present work aimed to elucidate the role of Angpt1 during embryonic 
neurogenesis in the zebrafish by examining the consequences of a nonsense mutation in 
the angpt1 gene, in parallel to the effects of increased angpt1 expression. In this study, 
the outcomes of loss- and gain-of-function of Angpt1 were analyzed in the cardiovascular 
and nervous systems, including a general phenotype characterization and an expression 
analysis of specific genes involved in neuronal and glial development, neural patterning 
and angiogenesis. 
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7.1 Angiopoietin 1 determines zebrafish embryonic 
phenotypes 
 
7.1.1 Loss of angiopoietin 1 causes severe cardiovascular defects and 
embryonic lethality 
The angpt1 point mutation in the Angpt1sa14264 line was confirmed by sequencing of the 
wild-type and mutated angpt1 alleles from embryos and adults obtained from distinct 
spawnings of Angpt1sa14264 HET pairs. Establishment of a phenotype-genotype 
association was demonstrated by the genotyping of 3 dpf embryos followed by the 
separate tracking of individuals with WT, HET and KO genotypes. 
The characterization of Angpt1sa14264 phenotypes was performed by observation of 
the developing embryos at seven stages of development. Prior to 24 hpf, no anatomical 
or physiological differences were found among embryos; However, the cardiovascular 
phenotype of Angpt1sa14264 KO animals started to diverge from the seemingly normal WT 
and HET phenotypes at 36 hpf. At this stage, the KO animals had slower cardiac rhythm 
and impaired blood circulation in the trunk and tail. Some hours later, at approximately 
48 hpf, they displayed significantly shorter bodies and slower beating hearts compared to 
WT and HET siblings. The KO phenotype continued to increase in severity and by 3 dpf 
the animals had visibly smaller bodies and heads compared to WT and HET siblings. 
While the WT and HET individuals exhibited a normal development until adulthood, and 
were viable, the KO fish died by 5 dpf. 
The lack of a discernible KO phenotype prior to 24 hpf could be partly due to an 
identical dissemination of maternal angpt1 between embryos of all genotypes. Another 
reason may be that the Angpt1-mediated vascular maintenance is only required in 
zebrafish after the establishment of the essential vascular structures, at approximately 24 
hpf. The lethal phenotype in zebrafish is compatible with both Angpt1 and Tek KO mice 
that die in utero as a result of severe cardiovascular defects (Dumont et al 1994, Suri et 
al 1996). Moreover, somatic TEK mutations in humans are associated with venous 
malformations and vascular dysmorphogenesis (Limaye et al 2009, Vikkula et al 1996). 
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7.1.2 Gain of angiopoietin 1 enhances blood perfusion 
Zebrafish overexpressing angpt1 were generated by Tol2 transgenesis. Depending on the 
success of the microinjection, animals displayed variable morphology, ranging from 
normal to severely deformed. Selection of transgenic animals for further experiments was 
based on two conditions observable at 3 dpf: normal body morphology and presence of 
strong expression of the EGFP marker in the heart, which signals a successful 
incorporation of the foreign DNA. 
The Ubi:angpt1 and HuC:angpt1 phenotypes were analyzed in 3 dpf injected fish. 
In both groups, an increase in heart rate was observed in comparison to the uninjected 
group. Although this observation reciprocates that of a decrease in the heart rate of 2 dpf 
angpt1 KO fish, the effect was curiously slightly stronger in HuC:angpt1 than in 
Ubi:angpt1 fish, suggesting that neuronal-specific and ubiquitous ectopic expression of 
angpt1 could have comparable effects in the cardiovascular system. Alternatively, the 
increase in heart rate by both promoters could be a side-effect of EGFP expression in the 
heart besides the activating effect of Angpt1. However, in line with the observed increase 
in heart rates in this study, previous studies of tissue-specific transgenic Angpt1 
overexpression in mice have reported increases in cardiac repair, skin vascularization and 
vessel enlargement, which could result in an increase in heart function and blood 
circulation (Suri et al 1998, Thurston et al 2005, Zeng et al 2012). 
In this study, angpt1 overexpression by either promoter failed to correlate with a 
clear phenotype for brain and overall body development, as shown by the non-significant 
changes in brain and body length compared with the uninjected control group. The lack 
of significant differences in the brains and bodies of the injected fish compared to the 
uninjected controls could be due to the mosaic expression of the Tol2 integration in the 
genome, which results in a transient expression of the foreign DNA. Considering this 
limitation, stable lines of angpt1 overexpression could be generated by crossing the 
injected fish with WT fish. The F1 generation would show stable ectopic overexpression 
of angpt1 driven by the promoters of interest (Kawakami et al 2000). 
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7.2 Angiopoietin 1 is implicated in embryonic angiogenesis, 
neural patterning and neuronal development 
 
7.2.1 Angiopoietins, Tek and Tie1 receptors are expressed during 
embryogenesis 
To assert the importance of the Angpt-Tek system in the early development of zebrafish, 
the relative expression of these angiocrine factors was assessed by RT-qPCR and their 
spatiotemporal expression was assessed by WISH. Seven stages of Turku WT zebrafish, 
from the 1-cell (0.2 h) stage to the protruding-mouth (72 h) stage, were used in the RT-
qPCR experiment whereas four stages of the same line, from the 1-cell (0.2 h) stage to 
the prim-5 (24 h) stage, were used in the WISH experiment. Peak expression was reached 
at the prim-5 (24 h) stage and the spatiotemporal expression suggests a maternal origin 
for angpt1 and tek mRNA in the zebrafish zygote. 
 
 
7.2.2 Loss of angiopoietin 1 perturbs neuronal organization, 
proliferation and differentiation 
A gene expression screening was performed, by RT-qPCR, on WT, HET and KO groups 
of whole 3 dpf Angpt1sa14264 fish. Loss of angpt1 perturbed the mRNA expression of 
several members of the Vegf family and the Angpt-Tek system. Foremost, tek was very 
significantly downregulated, while angpt2a was upregulated, indicating an overall 
balance towards blood vessel activation. In agreement with this observation, vegfaa and 
figf were upregulated, suggesting that the disruption of vascular integrity caused by the 
lack of angpt1 triggers an overall increase in pro-angiogenic vegf expression. Vegfba, 
however, was downregulated. A previous study on the role of vegfba in zebrafish 
development reported embryonic lethality of a MO-induced vegfba knockdown, due to 
brain-specific vascular and neuronal defects (Jensen et al 2015). The same study showed 
that the phenotype could be rescued by exogenous delivery of vegfba or vegfaa mRNA, 
or by hypoxia-induced upregulation of endogenous vegfaa expression. In the absence of 
angpt1, and with downregulation of tek and vegfba, compensation of neuronal and 
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vascular defects by endogenous upregulation of vegfaa is also supported by the fact that 
neurons in the spinal cord of zebrafish embryos express high levels of vegfaa, which 
promotes vessel branching at the neurovascular interface (Wild et al 2017). Expression 
of figf has previously been shown to localize in the head of developing zebrafish. 
Zebrafish lymphatic development seems to be primarily regulated by vegfc although figf 
has been shown to rescue lymphatic development specifically in the head, in the absence 
of vegfc (Astin et al 2014). Areas of chronic inflammation often have increased 
lymphangiogenesis, thus upregulation of figf could also come in response to disrupted 
lymphatic vessel homeostasis and chronic inflammatory processes caused by the loss of 
angpt1. 
To some extent, the observed upregulation of angpt2a could also underlie vascular 
compensation. Although ANGPT2 is mainly an antagonistic ligand of TEK, it has been 
reported to function as an agonist in the absence of ANGPT1 (Daly et al 2013). Though 
it is unclear that these functional properties are conserved in the zebrafish, upregulation 
of angpt2a could have a dual role in vascular compensation via the concomitant actions 
of Vegfaa and Figf in vessel activation and alternatively as an agonist of Tek. In addition 
to Tek, integrins may function as receptors for angiopoietins and Angpt-Itg binding may 
be enhanced in the context of low tek expression (Felcht et al 2012). Interestingly, 
downregulation of tek and the concurrent upregulation of itgb1b and angpt2a observed in 
the angpt1 KO fish were in accordance with a previous report highlighting ANGPT2-
mediated activation of ITGB1 (Hakanpaa et al 2015). 
Loss of angpt1 also disrupted the normal mRNA expression of members of the Wnt 
family. Wnt proteins play multiple and often partially redundant roles in development. 
However, the expression of wnt1 and wnt10b, seem to specifically localize and overlap 
in common neural progenitor regions of the developing zebrafish brain, such as the 
epithalamus, the midbrain-hindbrain boundary and the cerebellum (Duncan et al 2015). 
In the angpt1 KO fish, wnt1 and wnt10b were robustly downregulated, suggesting 
impairments in neural patterning processes of the brain regions where they are typically 
distributed. Although wnt1 and wnt10b do not seem to be required for the formation of 
the zebrafish midbrain-hindbrain constriction or the cerebellum, their early expression is 
temporally coordinated and plays a role in the maintenance and survival of progenitor cell 
populations at the midbrain-hindbrain boundary (Buckles et al 2004, Lekven et al 2003). 
In contrast with WNT2B in mammals, previous studies have not found evidence of its 
zebrafish ortholog, wnt2bb, being expressed in the developing CNS, but rather 
 63 
ambiguously in the early foregut organs (Poulain & Ober 2011). Although the zebrafish 
foregut organs are highly vascularized, it is unclear whether the slight upregulation of 
wnt2bb in the angpt1 KO fish underlies regenerative actions in the PNS or is simply a 
result of increased systemic pro-angiogenic signals in the gut. In the vertebrate nervous 
system, Sox proteins maintain NSC populations in undifferentiated states (Shi et al 2008). 
In the angpt1 KO fish, strong downregulation of sox2, but not sox10, indicates a deficient 
control of NSC proliferation and self-renewal, possibly leading to a premature onset of 
neuronal differentiation in the CNS, but not in the PNS. 
Neuronal and glial development is characterized by the temporal expression of 
important markers in their progenitors during phases of self-renewal, proliferation and 
differentiation. In the zebrafish brain, notch1a and several pax genes can be used as 
markers of neuronal proliferation and regionalization of the CNS, respectively (Krauss et 
al 1991, Louvi & Artavanis-Tsakonas 2006). The Notch pathway plays a role in the 
maintenance of NSC populations in the zebrafish brain and promotes glial precursor cell 
fates while restricting neuronal fates and terminal NPC differentiation (Koch et al 2013). 
In the angpt1 KO fish, both notch1a and pax5 were moderately downregulated. Together, 
these observations suggest that, in the absence of angpt1, NSCs may differentiate 
prematurely, disrupting the proper neuronal fate specification in the zebrafish brain. 
Importantly, broad expression of pax5 at the midbrain-hindbrain boundary of embryonic 
zebrafish could be functionally relevant to the regulation of this important neurogenic 
region (Pfeffer et al 1998). In contrast with the observed reduction in overall notch1a 
expression in the angpt1 KO fish, a recent study reported upregulation of the notch1a 
expression pattern specifically in 2 and 6 dpf brains of a zebrafish MO-induced 
knockdown of angpt1 (Chen et al 2015). Incompatible gene expression results in 
zebrafish knockouts and knockdowns have been extensively reported in other studies. A 
plausible explanation for this phenomenon could be the activation of compensatory gene 
expression in the presence of a critical deleterious mutation, an effect that does not seem 
to occur in translational or transcriptional knockdowns (Rossi et al 2015). Indeed, overall 
downregulation of notch1a as a result of vascular deregulation correlates with the fact 
that the NOTCH pathway is highly pleiotropic and NOTCH signaling regulates a variety 
of non-neuronal processes, such as cardiomyocyte proliferation and arterial-venous 
determination (Shawber & Kitajewski 2004, Zhao et al 2014). Endogenous NOTCH 
receptors and their ligands, Delta and Jagged, are membrane-bound proteins that require 
physical proximity of receptor- and ligand-expressing cells for NOTCH activation 
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(Schweisguth 2004). In the vertebrate brain, ECs are a major source of Delta (Shutter et 
al 2000). Thus, it is possible that EC destabilization accompanied by pericyte loss and 
vessel leakage caused by the lack of angpt1 may result in a global reduction of notch1a 
expression. Conflicting results in the relative expression of notch1a reported here and its 
spatiotemporal expression reported in a previous study (Chen et al 2015), could also be 
explained by the type of samples used in these experiments. In this study, cDNA from 
whole 3 dpf zebrafish was used in the gene expression screening, while the spatiotemporal 
pattern allowed for visualization of tissue-specific changes in expression. Therefore, the 
discordant notch1a expression results between whole angpt1 KO fish and angpt1 MO 
zebrafish brains could be due to a counterbalance of notch1a expression, where an overall 
systemic notch1a reduction eclipses a possible brain-specific increase. 
Pcna is a proliferation marker ubiquitously expressed in the neural tube of 1 dpf 
zebrafish. By 3 dpf, Pcna-positive cells are far more restricted to specific neurogenic 
areas, like the midbrain-hindbrain boundary (Wullimann & Knipp 2000). Downregulated 
pcna expression in the angpt1 KO fish indicates a sharp decrease in actively proliferating 
stem cells. Agreeably, nes expression was also moderately downregulated in the angpt1 
KO fish, suggesting an increase in terminal differentiation of NPCs. A previous study in 
zebrafish suggested that suppression of nes also enhances NPC apoptosis (Chen et al 
2010). Indeed, concomitant downregulation pcna and nes expression could denote either 
a widespread and rather disorganized NPC differentiation, or a substantial increase in 
NSC and NPC apoptosis. 
Th expression was also downregulated in the angpt1 KO fish, indicating that 
vascular dysmorphogenesis, by loss of angpt1, affects not only immature neuronal 
populations, but also differentiated ones. The astroglial markers apoeb and gfap were, in 
turn, slightly upregulated, supporting an alleged role for Angpt1 in the neurovascular 
niche, where astrocytes are structurally essential. As previously reported, ApoE was 
found in astrocytes and neurons of rat stroke brains, but absent from the neurons of non-
stroke control brains (Horsburgh & Nicoll 1996). There is further evidence that ApoE 
plays antagonistic roles in neurodegeneration, neuronal differentiation and 
neuroplasticity in mammals (Ferreira et al 2000, White et al 2001). Therefore, an increase 
in the expression of these glial markers in the angpt1 KO fish could come as a result of 
vascular destabilization followed by activation of neural repair mechanisms and 
heightened plasticity. Considering the alleged brain-specific upregulation of notch1a, 
these glial markers could also be increased owing to the promotion of astrogenesis. 
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7.2.3 Gain of angiopoietin 1 has mild effects on gene expression 
A gene expression screening was performed, by RT-qPCR, in groups of whole 3 dpf 
Ubi:angpt1, Ubi:mCherry and uninjected fish. The overexpression of angpt1 by the 
neuronal-specific HuC promoter did not produce detectable changes in gene expression 
of whole 3 dpf embryos (data not shown). Ubiquitous overexpression of angpt1 had far 
less pronounced effects in overall gene expression than its absence. Unsurprisingly, 
higher angpt1 expression promoted vascular quiescence and stabilization of vegf 
expression. Although tek expression remained unchanged, tie1 was moderately 
upregulated. As reported earlier, TIE1 may act as a regulator of TEK activity through the 
formation of heterodimer complexes. These complexes prevent TEK clustering and 
downstream signaling, but can be dissociated by ANGPT1 (Seegar et al 2010). Therefore, 
the observed increase in endogenous tie1 expression may be an inhibitory mechanism to 
counter excessive Tek activation. 
In zebrafish overexpressing angpt1, mRNA levels of itgb1b and itga5 were 
unchanged relatively to the uninjected controls, but were increased in comparison with 
the injected controls, suggesting that mCherry expression has a slightly negative influence 
on the expression of these two integrins. A similar trend was apparent for notch1a, where 
a statistically significant difference was only demonstrated between the angpt1 
overexpression group and the injected control group. However, in this case, a clear trend 
of notch1a upregulation was seen in overexpression of angpt1, compared to both injected 
and uninjected controls. Gfap expression was slightly downregulated in both angpt1 
overexpression fish and in the injected controls even though the difference in expression 
was only statistically significant between injected and uninjected control groups. This 
suggests that the negative effect on gfap expression is unspecific to angpt1 
overexpression, but rather a common reaction in both injected groups. 
Together, these results show that angpt1 overexpression had no effect on the neural 
patterning genes analyzed in this study and evoked only minimal consequences for 
neuronal proliferation in 3 dpf zebrafish. An angpt1-mediated upregulation of notch1a 
expression supports a role for angpt1 in the promotion of NSC proliferation and self-
renewal of NSC populations. Nevertheless, due to the diverse functions of Notch 
signaling, it remains unclear that the upregulated notch1a expression is neuronal-specific. 
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7.2.4 Changes in angiopoietin 1 modulate gene expression in the 
nervous and vascular systems 
The spatiotemporal profiles were studied in the contexts of angpt1 KO and 
overexpression to assess the qualitative effect of angpt1 on the expression patterns of the 
most relevant genes in the expression screening. To study the earliest effects of the loss 
of Angpt1, the angpt1 KO fish were discerned from their WT-like siblings by their 
obvious vascular phenotypes at 36 hpf. Additionally, the effect of angpt1 overexpression 
in the notch1a expression pattern was studied in ubiquitous and neuronal-specific 
contexts, in 3 dpf Ubi- and HuC-driven transgenesis, respectively. 
In the angpt1 KO fish, the most significant findings were the absence of wnt1 from 
the edge of the cerebellum and a substantially weaker nes distribution throughout the 
brain and spinal cord. These results correlate the absence of angpt1 from the midbrain-
hindbrain boundary with a specific disruption of wnt1 expression at this prominent 
morphological boundary in the zebrafish brain. The cerebellum is immediately adjacent 
to the isthmic organizer, a signaling center located in the midbrain-hindbrain boundary. 
Wnt signaling is critical for the development of the isthmus, which orchestrates the 
patterning and maturation of the zebrafish tectum and cerebellum (Buckles et al 2004). 
In contrast to wnt1, loss of angpt1 triggered a widespread reduction of nes, implying a 
reduction in neural progenitor-like cells. Reduced nes could suggest either an increase in 
NPC differentiation or apoptosis. Notably, the distribution of notch1a at 36 hpf was 
largely equivalent in angpt1 KO and WT-like fish, suggesting that the brain-specific 
changes in notch1a expression are secondary to wnt1 and nes. 
The ubiquitous overexpression of angpt1 induced a small increase in notch1a 
mRNA levels in 3 dpf fish. To investigate the neuronal specificity of notch1a 
upregulation in the transgenic fish, its spatiotemporal distribution was examined in both 
Ubi:angpt1 and HuC:angpt1 fish. No clear differences were detected between the brains 
of the overexpression fish and the uninjected controls. However, these results correlate 
angpt1 overexpression by both promoters with a stronger intensity of notch1a expression 
specifically in the primary head sinus, a cranial vein that plays an essential role in the 
drainage of midbrain and hindbrain blood vessels (Isogai et al 2001). While NOTCH 
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signaling is essential in the nervous system, it also promotes vascular differentiation and 
homeostasis (Zhang et al 2014). As a result of increased Angpt1-mediated vascular 
maturation, higher notch1a levels in stable post-morphogenic blood vessels may act as a 
signal for quiescence. 
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7.3 Conclusions and prospects 
This work provides evidence for a role of Angpt1 in developmental neurogenesis and 
offers some insight into the signaling pathways involved. The midbrain-hindbrain 
boundary of the zebrafish brain had been previously identified as a major site of angpt1 
expression. This study correlates the absence of functional Angpt1 with a partial loss of 
wnt1 expression adjacent to the midbrain-hindbrain boundary at a very early embryonic 
stage. Additionally, a widespread decrease in overall nes expression in the developing 
zebrafish CNS in the absence of angpt1 suggests a reduction in NPC numbers. 
Later in the embryonic development, variation in the relative expression of wnt1, 
wnt10b, sox2, notch1a, pax5, pcna and nes indicates severe disturbances in neural 
patterning processes in the CNS as well as a deregulation of neurogenesis. In parallel, 
loss of angpt1 increased the relative expression of the mature glial markers apoeb and 
gfap, while it negatively influenced th, a mature neuronal marker. Since the development 
of NSCs relies heavily on stimuli from their surroundings, the vascular destabilization 
and continuous pro-angiogenic signals by loss of angpt1 may result in the disruption of 
key NSC processes required for controlled growth responses. 
Studies on other models also offer important clues for the interpretation of these 
results. For instance, a study in human umbilical vein endothelial cells reported a positive 
regulation of b-catenin signaling by ANGPT1, resulting in the upregulation of Delta-like 
4, a NOTCH ligand (Zhang et al 2011). This supports the hypothesis of ANGPT1 as a 
regulator of WNT/b-catenin signaling, which in turn regulates Delta-like 4/NOTCH 
signaling. Although the modulation of NOTCH signaling by WNT is relatively known in 
the context of angiogenesis (Corada et al 2010), a conserved role for ANGPT1 in the 
regulation of these pathways in the context of neural patterning and neuronal development 
remains to be clarified. 
Future work will need to focus on the isolated effects of angpt1 expression in the 
CNS and in determining the functional relevance of different Angpt1 receptors, such as 
integrins, for the modulation of NSC and NPC responses. The expression of other wnt, 
notch and delta genes should also be examined to further characterize the complex 
implications of Angpt1 in this system. Furthermore, proliferation assays and 
immunostainings of mature neuronal markers may be useful to observe the changes in the 
proliferation and differentiation of specific neuronal and glial cell populations. 
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The ANGPT-TEK system remains the subject of exciting translational research, not 
only in pathological angiogenesis, but also in vascular brain disorders. Reinforced by a 
presumptive dual function in angiogenesis and neurogenesis, ANGPT1 holds the 
potential to become a promising agent in CNS regeneration following acute vascular 
injury. 
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10 APPENDICES 
 
10.1 Appendix A | Supplemental figures 
 
Figure S1 | Control samples for WISH experiments. a, Sense probe controls (n = 2 per stage) for 
previously unpublished hybridization clones of angpt2a, angpt2b and tie1 in 0, 5, 10 and 24 hpf Turku WT 
zebrafish embryos. Scale bars, 200 µm. b, Sense probe controls (n = 2) for new hybridization clones of 
itgb1b and wnt1 in 36 hpf Angpt1sa14264 WT-like embryos. Scale bars, 200 µm. c, Expression patterns of 
angpt1 and notch1a in 3 dpf Ubi:mCherry injected controls (n = 2). Scale bars, 200 µm. 
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10.2 Appendix B | Supplemental tables 
Table S1 | Summary of RT-qPCR normalized mean and SD values of WT, HET and KO groups of 3 
dpf Angpt1sa14264 fish. 
Biological 
process 
Gene 
WT HET KO 
Mean SD Mean SD Mean SD 
Angiogenesis 
angpt1 3.26E-03 3.33E-04 1.82E-03 1.13E-04 4.94E-04 6.77E-05 
angpt2a 1.97E-04 3.05E-05 1.96E-04 1.43E-05 3.20E-04 6.66E-05 
angpt2b 4.74E-04 3.42E-05 5.07E-04 1.22E-05 5.24E-04 3.86E-05 
figf 1.03E-03 3.00E-05 1.12E-03 6.24E-05 1.40E-03 1.21E-04 
itga5 5.61E-03 6.74E-04 5.11E-03 3.09E-04 4.62E-03 8.27E-04 
itgav 7.35E-02 2.91E-03 7.44E-02 4.46E-03 7.97E-02 2.23E-03 
itgb1a 3.80E-02 1.73E-03 3.71E-02 2.33E-03 4.15E-02 3.91E-03 
itgb1b 4.90E-02 4.16E-03 5.16E-02 2.61E-03 6.47E-02 4.63E-03 
tek 2.78E-04 5.50E-06 2.50E-04 1.22E-05 1.48E-04 2.00E-05 
tie1 2.25E-03 2.66E-04 2.24E-03 2.11E-04 1.96E-03 1.43E-04 
vegfaa 6.57E-03 2.40E-04 6.22E-03 6.99E-05 8.21E-03 5.23E-04 
vegfab 4.84E-03 5.66E-04 4.18E-03 2.04E-04 4.40E-03 2.57E-04 
vegfba 2.53E-03 2.42E-04 2.23E-03 1.23E-04 1.65E-03 5.53E-05 
vegfc 1.07E-03 7.12E-05 1.00E-03 1.08E-04 1.12E-03 6.56E-05 
Neural patterning 
epha4a 1.17E-02 7.58E-04 1.13E-02 3.99E-04 1.09E-02 3.67E-04 
ephb4a 9.28E-03 4.81E-04 8.26E-03 4.43E-04 8.66E-03 4.27E-04 
ephb4b 5.10E-03 2.49E-04 4.77E-03 1.10E-04 5.02E-03 1.45E-04 
sox2 3.14E-02 5.56E-04 2.98E-02 2.35E-03 2.05E-02 7.33E-04 
sox10 3.43E-03 3.25E-04 2.98E-03 3.98E-04 2.70E-03 8.43E-04 
wnt1 1.32E-03 2.10E-05 1.25E-03 1.27E-04 5.65E-04 1.11E-04 
wnt2bb 2.22E-03 5.24E-05 2.10E-03 2.32E-04 2.74E-03 2.57E-04 
wnt10b 8.33E-04 2.77E-05 8.38E-04 4.30E-05 4.81E-04 3.88E-05 
Neuronal and glial 
development 
apoea 1.94E-01 2.61E-02 1.79E-01 1.92E-02 2.03E-01 9.53E-03 
apoeb 2.71E-01 2.19E-02 2.47E-01 2.13E-02 3.32E-01 2.86E-02 
gfap 3.25E-02 3.75E-03 2.97E-02 3.59E-03 3.90E-02 1.62E-03 
nes 2.34E-03 2.47E-04 2.19E-03 2.58E-04 1.37E-03 2.13E-04 
notch1a 9.38E-03 1.78E-03 7.71E-03 5.66E-04 4.99E-03 4.23E-04 
pax2a 9.41E-03 9.27E-04 8.69E-03 1.19E-03 1.06E-02 1.37E-03 
pax2b 4.13E-03 5.03E-04 3.68E-03 2.72E-04 4.62E-03 4.06E-04 
pax5 3.99E-03 5.12E-04 3.67E-03 4.29E-04 1.96E-03 1.78E-04 
pcna 1.17E-01 2.20E-03 9.61E-02 1.58E-03 4.55E-02 1.38E-02 
th 2.83E-03 1.80E-04 2.72E-03 7.05E-05 2.17E-03 1.89E-04 
th2 2.87E-05 6.76E-06 2.92E-05 3.56E-06 4.05E-05 1.43E-05 
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Table S2 | Summary of RT-qPCR normalized mean and SD values of Ubi:angpt1, Ubi:mCherry and 
uninjected groups of 3 dpf transgenic fish. 
Biological 
process 
Gene 
Ubi:angpt1 Ubi:mCherry Uninjected 
Mean SD Mean SD Mean SD 
Angiogenesis 
angpt1 1.14E-01 2.04E-02 2.88E-03 4.76E-04 2.96E-03 4.44E-04 
angpt2a 1.31E-04 2.40E-05 1.65E-04 3.00E-05 1.52E-04 2.58E-05 
angpt2b 7.81E-04 4.49E-05 7.20E-04 1.47E-05 8.12E-04 1.05E-04 
figf 1.11E-03 1.26E-05 1.13E-03 8.96E-05 1.10E-03 8.70E-05 
itga5 9.70E-03 8.13E-04 7.87E-03 3.48E-04 8.09E-03 7.58E-04 
itgav 9.26E-02 6.40E-03 8.54E-02 1.25E-02 9.04E-02 8.64E-03 
itgb1a 3.97E-02 6.92E-03 3.35E-02 1.03E-03 3.50E-02 5.25E-03 
itgb1b 5.44E-02 2.76E-03 4.35E-02 3.42E-03 5.14E-02 4.04E-03 
tek 1.49E-04 2.16E-05 1.35E-04 4.13E-05 1.42E-04 2.79E-05 
tie1 2.69E-03 2.12E-04 1.92E-03 1.23E-04 2.14E-03 8.94E-05 
vegfaa 6.11E-03 4.44E-04 5.15E-03 3.27E-04 5.71E-03 3.75E-04 
vegfba 1.94E-03 2.22E-04 1.66E-03 1.08E-04 1.92E-03 3.41E-04 
Neural patterning 
epha4a 1.42E-02 1.29E-03 1.22E-02 1.79E-03 1.29E-02 1.08E-03 
sox2 2.19E-02 1.05E-03 2.26E-02 1.84E-03 2.41E-02 2.17E-03 
sox10 2.32E-03 2.64E-04 2.77E-03 1.60E-04 2.83E-03 3.47E-04 
wnt1 1.23E-03 7.25E-05 1.22E-03 8.97E-05 1.23E-03 1.17E-04 
wnt2bb 2.09E-03 8.21E-05 2.03E-03 1.16E-04 1.98E-03 1.60E-04 
wnt10b 9.05E-04 8.01E-05 9.91E-04 8.78E-05 8.61E-04 8.30E-05 
Neuronal and glial 
development 
apoea 1.21E-01 1.03E-02 1.46E-01 1.94E-02 1.37E-01 2.14E-02 
apoeb 2.65E-01 4.67E-02 2.82E-01 1.31E-02 2.07E-01 3.65E-02 
gfap 3.66E-02 1.77E-03 3.40E-02 1.13E-03 4.48E-02 3.47E-03 
nes 2.65E-03 6.17E-05 2.35E-03 2.79E-04 3.07E-03 5.81E-04 
notch1a 1.60E-02 1.51E-03 1.19E-02 2.17E-03 1.31E-02 2.32E-04 
pax5 3.83E-03 2.98E-04 3.16E-03 3.16E-04 3.28E-03 4.00E-04 
pcna 1.32E-01 1.36E-02 6.51E+04 1.13E+05 1.33E-01 1.53E-02 
th 2.73E-03 1.22E-04 2.48E-03 4.66E-05 2.56E-03 2.00E-04 
th2 2.64E-05 5.74E-06 2.60E-05 8.16E-06 3.19E-05 1.31E-06 
 
